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                     ABSTRACT 
Biofilms are complex structures consisting of bacterial colonies encased in a 
mucilaginous protective coating, and represent major virulence factors contributing to the 
chronicity of many microbial infections. Biofilms are estimated to be involved in more than 
60% of nosocomial infections and associated with about 80% of all chronic infections. The 
aim of the current study was to isolate and characterize bacteriophages infecting biofilm-
forming multi-drug resistant E. coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, 
Enterobacter cloacae and Shigella dysenteriae, and to study the potential of those 
bacteriophages to control bacterial planktonic cells and biofilms. 
Clinical bacterial strains were selected on the basis of their biofilm-forming ability. 
Five bacteriophages were isolated from sewage water samples and named MJ1, AZ1, MJ2, Z 
and WZ1, where MJ1 infects E. coli, AZ1 infects P. aeruginosa, MJ2 infects E. cloacae, Z 
infects K. pneumoniae, and WZ1 infects S. dysenteriae. All phages had a narrow host range 
(only few bacterial strains). Adsorption rates of all phages to their hosts were significantly 
enhanced in the presence of MgCl2 or CaCl2. Each phage was classified into a viral family 
based on electron microscopy analysis, and assayed for heat- and pH-stability, latent period, 
burst size per cell, protein composition by SDS-PAGE, nucleic acid composition by agarose 
gel electrophoresis, and range of DNA bands upon EcoR enzyme restriction digestion. 
Phages MJ1 and WZ1 were assigned to the family Myoviridae, and displayed stability 
between 37-65 °C, and pH 5-11, with 21 and 24 minutes latent periods, and burst sizes of 300 
and 430 phages per cell, respectively. MJ1 had a genome size of approximately 32 kb, with 
eleven proteins (12-110 kDa), and produced 2 DNA bands of upon digestion, whereas WZ1 
had a genome of ~38 kb, with twelve proteins (22-150 kDa), and produced 3 bands upon 
digestion. Phages AZ1 and Z were assigned to the family Siphoviridae, and displayed 
stability between 37-70 °C, and pH 3-11 (for AZ1) or pH 5-11 (for Z), with a 33 min and 24 
min latent periods, and burst sizes of 326 and 320 phages per cell, respectively. AZ1 had a 
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genome size of ~50 kb, with seventeen proteins (12-110 kDa), and produced 9 DNA bands 
upon digestion, whereas Z had a genome of ~36 kb, with six proteins (18-65 kDa), and 
produced 2 bands upon digestion. Phage MJ2 was classified in the family Podoviridae, and 
displayed stability at 37-65°C, and at pH 5-11, with a 21 min latent period and a burst size of 
350 phages per cell. MJ2 had a genome size of ~40 kb, with eleven proteins (12-150 kDa), 
and produced 2 DNA bands of upon digestion. 
The isolated phages were checked for their lytic activity against suspensions of their 
host bacteria. Phages MJ1, MJ2, AZ1, Z and WZ1 significantly reduced log-phase growth of 
bacterial cultures, showing no resistance within 5 hrs, and were effective in reducing the 
biofilm biomass of their respective hosts after 48 hrs, with more than 2-fold, 3-fold, 2-fold, 3-
fold and 1.5-fold reduction, respectively. The susceptibility of the hosts to lysis by the 
specific phages were compared in both planktonic form (stationary phase) and in biofilm 
phenotype. Bacteria in biofilms and stationary planktonic phase were killed at a lower rate 
than log-phase planktonic bacteria. Additionally, E. cloacae and K. pneumoniae biofilm-
formation was induced on stainless steel plates for 48 hrs, and tested for lysis by their 
respective phages. Significant biofilm reduction, but no total eradication, was detected for 
both bacteria under these conditions. Interestingly, the log-phase growth of P. aeruginosa and 
the 48 h biofilm biomass (up to 6-fold reduction) were significantly reduced by treatment 
with phage cocktail (MJ1, KH-49, AZ1) as compared to treatment with the single phages.  
In conclusion our findings suggest that waste water is a good source for finding 
bacteriophages against newly emerging antibiotic resistant bacteria. Phages can be used to 
control bacteria both in planktonic form and in biofilms. Single phage species may not be 
able to completely eradicate bacterial biofilm, but our present findings suggest that phage 
cocktails offer greater potential in eradication of bacteria (both in suspension and biofilms), 
and such cocktails can be further used for elaborated phage therapy studies. 
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Chapter 1 
INTRODUCTION 
1.1 BACTERIOPHAGE 
 The term “bacteriophages” was coined by D’Herelle which means bacteria 
eater (Summers, 2001).  Bacteriophages are commonly known as phages or bacterial 
viruses that specifically infect and lyse bacteria (Nakai and Park, 2002). It has been 
found that phages killed around (4–50 %) of the bacteria produced on daily basis. 
Bacteriophages are one of the greatest reservoirs of genetic diversity on the earth 
(Suttle, 2005). The idea to treat bacterial infections using phage therapy was set forth 
almost a century ago with the discovery of bacteriophages (Inal, 2003). A British 
physician in 1959 for the first time reported the effects of phages. He observed the 
antibacterial effects of filtered water from the river Ganges against Vibrio cholerae. But 
the actual discovery of phages is credited to two other researchers named Frederick Twort 
(1915) and Felix D’Herelle (1917). They independently described phages as filterable, 
transmissible agents capable of bacterial lysis (Sharp, 2001). Felix D’Herelle performed 
several experiments on bacteriophages and saw the potential for phages to be used as 
therapeutic agents and became the first proponent of ‘phage therapy’ which he hoped would 
hold the cure for bacterial diseases. Before to performed experimental trials on human being, 
D’Herelle checked the safety of his phage preparations on himself by ingesting and injecting 
them. Bacillary dysentery and cholera were the first two bacterial diseases for which he 
performed human trials.  He was also successful in treating few cases of bubonic plague using 
Yersinia phage (Summers, 2001). In 1940, d’Herelle and a pharmaceutical company named as 
Eli Lilly started the commercialization of therapeutic phage preparations used to treat human 
bacterial infection in France (Fischetti, 2001; Stoner, 2002). Phage therapy had wide varieties 
of applications ranging from cure of wound infections to gastrointestinal and respiratory 
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infections. There were multi-factors that were considered to be involved in this inconsistency, 
including the limited scientific rigor applied to the experimental design. Although consistent 
with the standards of the time, there were few reported cases where rigorous studies, such as 
double-blind trials, were carried out. Another big problem was lack of knowledge in 
understanding phage biology which is still being debated (Summers, 2001). For instance, a lot 
of big pharmaceutical companies began preparing commercial quantities of phages for 
treatment of a range of infections. Some phage preparations were advertised as containing up 
to 100 different phages. However, many of these polyvalent preparations were often found to 
having no activity. So these issues along with the commencement of World War II and the 
discovery of penicillin, which was far easier to produce and had a much broader spectrum 
compared to phage therapy, led to the decline in western countries research regarding phage 
therapy (Summers, 2001). However, it continued unabated in the former Soviet Union, where 
bacteriophage therapy continues to be used routinely. In particular, the Eliava Institute in 
Tbilisi, Georgia, became, and remains, the principal institute for phage therapy globally 
(Kutateladze and Adamia, 2008). Although phage therapy was discontinued in the West, 
research into phage virology has been integral to the development of genetics and molecular 
biology due to their simple genomes and ability to be rapidly propagated using simple media 
and bacterial cultures (Pennazio, 2006). Furthermore, the past 20 years have seen a 
resurgence of interest in Western countries in phage therapy research efforts to combat the 
rise in antibiotic resistant bacteria (Chanishvili et al., 2001). In the last few years, there is an 
increase in antibiotic resistance in bacteria due to this reason researchers are trying to control 
the emergence of antibiotic resistance bacteria and devised phage therapy for controlling 
bacteria instead of frequent use of antibiotics (Nakai and Park, 2002). According to World 
Health Organization (WHO), 60 % infections are drug-resistant and it is hoped that control 
therapies will be developed soon to combat and treat pathogenic and antibiotic-resistant 
bacteria (Inal, 2003).  
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1.2  CLASSIFICATION OF PHAGES 
Bradley in 1967 proposed phage classification scheme which has been adapted 
for present phages classification by International Committee on Taxonomy of Viruses 
(ICTV) (Bradley, 1967). Bacteriophages are classified on the basis of several 
characteristics such as morphology, type of nucleic acids and presence or absence of 
an envelope or lipid (Table 1.1) (Fauquet et al., 2005). According to Ackermann 
(2009) bacterial viruses include fourteen (14) officially accepted families and at least 
five (5) other potential families awaiting classification and approximately 5,500 
prokaryote viruses have been examined in the electron microscope. It is hypothesized 
that majority of bacteriophages consists of tailed phages (96 %) while a small number 
of phages (3- 4 %) belong to the remaining families. All the tailed phages fell into 
three families i.e. Siphoviridae, Myoviridae and Podoviridae (Ackermann, 2003). 
New Phages are discovered on daily basis therefore classification is open-ended and 
the ICTV is unable to schedule phage classification properly. Chemically 
bacteriophages consist of two main components i.e. a protein or lipoprotein capsid 
and genetic material (DNA or RNA) (Figure 1.1). The genetic material of phage is 
protected by a protein coat or capsid (Ackermann, 2007). A tail is attached to the 
capsid having fibers that help in binding of phage to the bacterial cell (Ackermann, 
1998). Phages genome mostly consist of double-stranded DNA or RNA but there are 
some other small group of phages having single-stranded DNA, single-stranded RNA 
with size ranging from a few to several hundred kb (Frost et al.,  2005). 
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 Figure 1.1: Typical morphological structure of a bacteriophage.  Phage having an   
icosahedron head, long tail and tail fiber. Figure adapted from Serwer et al. (2008). 
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1.3  ISOLATION AND PREVALENCE OF PHAGES 
The most abundant entities on earth are bacteriophages especially in the 
aquatic environment. Bacteriophages include viruses of Eubacteria and Archaea 
(Ackermann, 2007). Soil, water, sewage, compost, manure, humans’ and animals’ 
body (gut, saliva, faeces, skin, oral cavity, urine) (Ashelford et al., 2003) and even the 
food stuffs which we eat on daily basis are sources form where bacteriophages have 
been isolated by many researchers (Neve et al., 1994). There are certain well adapted 
phages which can withstand harsh environmental conditions such very high 
temperature up to  95 
o
C and a very low values of pH such as 1.3 (Marks et al., 2000). 
Bacteriophages are considered as most prevalent entities on earth (Pedulla et al., 
2003). The phage population size has been estimated that is very high in numbers as 
compare to other microorganisms. For example, it is supposed that aquatic 
environments have total phage numbers of more than 10
31
 (Hendrix et al., 2002; 
Ashelford et al., 2003). Terrestrial environment have shown 10
7
 phages per gram of 
soil (Ashelford et al., 2003) and sewage having phage numbers ranging from 10
8
 to 
10
10
 per milliliter (Sharp, 2001). It has also been shown that phages are greater in 
number than bacterial population in all important environments studied and are 
therefore considered to be the most predominant life-like form on earth (Furuse, 1987; 
Neve et al., 1994).  
1.4 BACTERIOPHAGE LIFE CYCLES  
Phages are categorized into two groups on the basis of virulent or temperate 
temperature nature. Phages having virulent nature always go through the lytic cycle 
which causes lysis of the host cell releasing phage progeny (Engelkirk and Burton, 
2006). While the temperate phages have two life cycles one is lysogenic and the other 
is lytic (Little, 2005).  
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1.4.1 Lytic Life Cycle  
 Phage binding occur to receptor in the host cell membrane which is followed 
by injection of the nucleic acid to the host cell (Inamdar et al., 2006). Adsorption of 
phage to the host bacteria is affected by some external factors and certain other host 
physiological conditions. For successful binding and attachment to the host bacterium 
some cofactors such as Ca
2+
 and Mg
2+
, divalent cations or sugars may be needed 
(Guttman et al., 2005). After phage adsorption, transfer of nucleic acid takes place. 
The mechanisms for transfer are specific for different phages. Phage nucleic acid is 
transferred to the cytoplasm of host bacterium cell while capsid and tail remain 
outside the cell (Letellier et al., 2004). Penetration of the tail tip occurs through the 
peptidoglycan layer and the inner membrane to release nucleic acid into the cell 
(Inamdar et al., 2006). For synthesis of its different components such as viral nucleic 
acid and proteins phage exploits host cell machinery such as RNA polymerase, DNA 
polymerase, ribosome, amino acids and nucleotides (Engelkirk et al., 2011). After 
biosynthesis of various components, viral assembly takes place. Release of the 
progeny into the exterior in case of most phages can only be done once the host cell 
membrane is burst. Bacterial lysis is the last stage in the lytic life cycle (Figure 1.3). 
This is however, not the case for some phages, for instance, filamentous phages 
whose progeny are released by extrusion without disruption of the host cell membrane 
(Young et al., 2002). With the exception of phages with ssDNA and ssRNA, lytic 
phages encode and involve an enzyme, known as an endolysin which degrades the 
bacterial peptidoglycan (Blasi and Young, 1996).  
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1.4.2 Lysogenic Life Cycle  
In this type of life cycle the viral nucleic acid is integrated into the host 
bacterial chromosomal DNA. This incorporated fragment is known as the prophage. 
In provirus form a virus is in latent state and its replication occurs with the genome. 
Bacteria having viral DNA in their genomes are called lysogens (Stansfield et al., 
1996). Lytic genes are also present in temperate bacteriophages but are not expressed 
due to presence of the repressors. In this way phage nucleic acid replication takes 
place with in the host choromosomal DNA before the lytic stage become switch on. 
The switching mechanism of lysogen to lytic form is different among bacteriophages. 
The mechanisms of switching are different in different phages (Little, 2005). 
Bacteriophage λ is the best studied example describing this phenomenon. Phage 
lambda genome has certain functional modules that perform specific functions in the 
life cycle. CII, an activator is the determining factor in the pathway followed post 
infection (Little, 2005). 
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Figure 1.2: Lytic life cycle of bacteriophage infection. Figure describing different events 
that occur during lytic life cycle of phage, such as attachment, adsorption, transfer of nucleic 
acid, penetration, biosynthesis, assembly and release of progeny virions (Ahiwale et al. 2012). 
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Figure 1.3: Lysogenic life cycle of bacteriophage infection. Figure describing different 
events that occur during lysogenic life cycle of phage, such as attachment, adsorption, 
transfer of nucleic acid, incorporation of phage DNA into bacterial chromosome (prophage), 
replications of virions [ Ahiwale et al. ( 2012)]. 
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1.5 BIOFILM AND ITS ROLE IN HUMAN INFECTIONS 
Biofilms are group of microorganisms in which cells are adhered to each other 
on a surface encased inside a self-produced extracellular polymeric substance. 
Biofilm has a complex nature and is composed of extracellular DNA, lipids, proteins, 
and polysaccharides. This biofilm is cause of diseases and provides virulence to 
microorganisms to cause chronic diseases. Those microbes which are growing as 
biofilm are extremely unresponsive to commonly used antibiotics and antibacterial 
drugs (Hall et al., 2004). Biofilms are present everywhere in nature and can be found 
in industrial places, hotels, waste water channels, bathrooms, labs and hospital 
settings. Its formation can occur on both living and non-living surfaces. Generally, 
biofilms  formation occur on surface of hard substrates submerged in or exposed to an 
aqueous solution, although they can be formed as floating mats on liquid surfaces. 
Due to increased use of indwelling medical devices which can cause infections, it has 
gained great importance (Lear and Lewis, 2012). There are persister cells, which is 
small sub population in biofilms which may cause resistance to antibiotics in biofilms. 
These cells have no mutations but are dormant having a very slow metabolic rate and 
grow very slowly which make the cells in-sensitive to the anti microbial effect of 
antibiotics. During biofilm formation many species of bacteria are able to 
communicate with one another through a mechanism called quoreum sensing. It is a 
system of stimulus to co-ordinate gene expression on other cells and response related 
to the density of their local population. During quorum sensing signaling molecules 
attach to receptors of new bacteria and help in transcription of genes within a single 
bacterial species as well as between diverse species (Miller and Miller, 2011). Due to 
the extreme resistance of these biofilms to antibiotics and host defense mechanisms, 
effective treatment of such a diseases is very difficult (Costerton et al., 1995). 
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According to the National Institutes of Health (NIH) about  80 % of all chronic 
infections  are due to  biofilms (Monroe  et al., 2007) and in all microbial infections 
about 65 %  are related to growth of biofilm (Potera, 1999). Nearly all bacteria can 
form biofilms when suitable conditions are available (Wilson et al., 2001). A list of 
bacterial infections is shown (Table 1.2). 
 
Table 1.2: Biofilm associated human infections (Costerton et al., 1999) 
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1.6 BIOFILM DETECTION 
Biofilm can be detected by collecting sample either through forceful scrapping 
with sterile scalpel, forceful swabbing from the site or sonication of the catheter-intra 
and extraluminally. There are certain methods used for detection of biofilms such as 
Tissue culture plate method, Tube method, Congo red agar method and microscopy 
(Maiti et al., 2006) 
1.6.1 Tissue Culture Plate Method (TCP)  
The tissue culture plate assay was described by Christensen et al. (1985). TCP 
method is most commonly used and is accepted as most suitable assay for biofilm 
detection.  In this procedure polystyrene tissue culture plates are used for growth of 
microorganisms. After washing the plates are fixed with 2 % sodium acetate and 0.1% 
(w/v) crystal violet for staining biofilm. ELISA reader is used to detect and measure 
biofilm formation by measuring optical density. 
1.6.2 Tube Method (TM) 
It is qualitative method which assists biofilm formation. Trypticase soy broth 
(TSB) with glucose (1 %) in tubes is used to grow microorganisms for 24 hours. The 
tubes grown with microorganisms are then discarded followed by washing with 
phosphate buffer saline (PBS) and 0.1 % crystal violet is used to stain the adhered 
cells or biofilm. After washing the tubes are dried. When a visible adhered film lines 
the wall and bottom of the tube, it is considered positive result (Christensen et al., 
1982). 
1.6.3 Congo Red Agar Method (CRA)  
According to this procedure brain heart infusion (BHI) agar is used to grow 
microorganisms with Congo red and sucrose (5%). A positive result is considered 
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when black colonies with a dry crystalline consistency are detected (Freeman et al., 
1989). 
1.6.4 Microscopy 
Microscopy is the most common way for detection of morphological aspects 
and enumeration of microbes on surfaces. There are sub types of microscopy i.e. this 
may involves direct counting   methods   such  as  light   microscopy, epifluorecene 
microscopy, scanning electron microscopy (SEM), Confocal Laser Scanning 
Microscopy (C-LSM).  Biofilms of more thickness canbe studied either by computer 
enhanced microscopy (Walker and Keevil, 1994) or by C-LSM (Lawrence et al., 
1991; Caldwell et al., 1992) 
1.7 PHAGES AS BIOFILM CONTROL AGENTS 
Eradication of biofilms using phages is an efficient and novel strategy (Merril 
et al., 2003). Therapeutic use of bacteriophages to control bacterial infections is called 
Bacteriophage or Phage therapy. Bacteriophages can be used to treat bacterial 
infections that are highly resistant to antibiotics (Hadas et al, 1997; Corbin et al., 
2001).  During an in-vitro study when silicone catheters were pretreated with phages 
significant reduction in biofilm formation by S. epidermidis was observed (Curtin and 
Donlan, 2006). Bacteriophage ability to inhibit or reduce formation of biofilm in-vivo 
has also been proven. Bacteriophages (lytic) were shown to result in survival of 
septicemic mice infected with multidrug-resistant bacteria (MDR) P. aeruginosa and 
K. pneumoniae (Vinodkumar et al., 2008). A genetically engineered lytic phage 
having a biofilm degrading enzyme has showed more efficient eradication of biofilm 
than wild type phages (Lu and Collins, 2007). Certain issues associated with phage 
therapy such as host specificity, efficacy, safety and phage distribution, however still 
need to be solved (Merril et al., 2003). Bacteriophage during lytic phase of cycle 
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infects host bacterial cell in such a way that caused lysis and leads to liberation of 
next progeny even when the deficiency of  nutrients  (Corbin et al., 2001; Hadas et 
al., 1997). Phages have been applied as a therapeutic agents for the curing various 
infectious diseases caused by bacteria in animals and  plants (Barrow et al., 1998). 
Phages have been testified in treating different infectious diseases e.g. lung infections, 
osteomyelitis,  meningitis, and other chronic wound infections caused by a variety of 
microbes including P. aeruginosa, E. coli, Salmonella, Shigella, Streptococcus and 
Staphylococcus (Monk et al., 2010). Different antimicrobials are used for prolonged 
treatment of various bacterial chronic infections especially when the infections are 
untreatable or undergone surgery. Biofilm forming  organisms  confer resistance in 
different ways to tolerate such antimicrobials (Doolittle et al., 1995). However, 
Kallings proved that in blood phage remains active for sometime and becomes in 
active when incubation time is increased. A very low concentration of antibodies 
against phage is detected in blood (Donlan, 2009; Kallings, 1961). Phage therapy has 
some unique advantages over antibiotics listed in detail (Table 1.3). There are also 
certain bacteria that can develop resistance to phages, but it is also very easy to isolate 
new phage comparably to develop new antibiotics. In a very short period of time a 
new phage can be isolated for the new antibiotic resistant strain of bacteria. It is 
hypothesized that as the bacteria developed resistance at the same time the phage 
naturally evolves alongside. Similarly at the appearance of super bacterium, the 
supper phage is also there to attack (Abhilash et al., 2009).  
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1.8 Aims and Objectives 
The main aim of our study was to demonstrate the application of phage therapy for 
clinically important multi-drug resistant (MDR) bacteria. The following specific 
objectives accomplished our research goal. 
(1) Isolation and Identification of biofilm forming clinical antibiotic resistant bacteria, 
Escherichia coli, Pseudomonas aeruginusa, Kliebsilla pneumoniae, Shigella 
dysenteriae and Enterobacter cloacae  from local hospitals and testing their 
biofilm formation abilities in 96 well pates. 
(2) Isolation and characterization of specific bacteriophages infecting the isolated   
biofilm forming clinically important multi-drug resistant (MDR) bacteria. 
(3) Studying the effect of the isolated phages against planktonic cultures of targeted 
bacterial strains. 
(4) Biofilm formation of Escherichia coli, Pseudomonas aeruginusa, Kliebsilla 
pneumoniae, Shigella dysenteriae and Enterobacter cloacae and demonstration of 
phage therapy against their biofilms. 
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Chapter 2 
  REVIEW OF LITERATURE 
2.1 HISTORICAL BACKGROUND AND BIOFILMS IN NATURE 
Observation of microbial biofilm is directly related with the discovery of 
simple microscope. A Dutch researcher, Antoni van Leeuwenhoek, for the first time 
observed ‘animalcule’ on surfaces of tooth by using a simple microscope and this was 
considered the microbial biofilm discovery (Costerton et al., 1999).  In 1973, a study 
was conducted by Characklis on microbial slimes formation in industrial water 
systems. He showed that the bacterial cells were not only persistent but also 
resistantant to disinfectants e.g. chlorine. Costerton, in 1978, coined the term biofilm 
and played a key role in alerting the world about the importance of the biofilm. He put 
forth the biofilm theory that describes the mechanisms whereby microorganisms bind 
to biological (living) and inert (nonliving) materials and get benefits of this ecologic 
niche. In the last 20 years, research work regarding biofilm has been based on tools 
such as scanning electron microscopy (SEM), microarray assays, or standard 
microbiological culture procedures. Important findings  such as biofilm ultra-structure  
characterization by confocal laser scanning microscope (C-LSM) and detection of 
genes involved in bacterial binding to surface for initiating biofilm formation have 
strengthened our understanding about biofilm (Characklis, 1973). Bacteria inside 
biofilm have a protected mode of life allowing them to survive in harsh environmental 
conditions. Bacterial biofilms can be formed on any surface having humidity such as 
teeth having plaque, river stones having slippery slime, a flower vase having gel-like 
film inside and tissue with infection (Costerton et al., 1999). Other places include 
kitchen, sinks, on contact lenses, in gut linings of animals etc. Individual cells
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 released from these bacterial biofilms become scattered and multiplied 
making colonies on other places leading to formation of biofilm over there. Bacterial 
biofilms have been known for corrosion of pipes, water filter clogging and drinking 
water contamination (Donlan, 2001). Researchers have tried to understand triggers 
that cause planktonic bacterial cells to adapt to biofilm nature (Costerton et al., 1999). 
Biofilms are pervading and becoming a great problem in medical (hospitals), 
environmental and industrial settings due to specific properties such as high antibiotic 
resistance, avoiding damage from UV radiations and chemical biocides, increased 
genetic exchange frequencies, altered biodegradability and enhancement in secondary 
metabolites production (Costerton et al., 1987; O’Toole et al., 2000). 
2.2 UNDERSTANDING BIOFILMS 
Biofilms are microbial associations in which microbes exude polymers called 
as extracellular polymeric substances (EPS). Microorganisms that have the ability to 
form biofilm can bring about disease progression. They can secret endotoxins in 
blood stream and caused septicaemia when the aggregates of cells are detached. 
Microorganisms producing biofilm provide the platform for  the emergence of the 
resistant bacteria (Donlan, 2009). There is key role of biofilm in antibiotic resistant 
infections.  In food industry, microbial adhesion and biofilms are of great importance 
and such adhesion and biofilm formation of microbes take place on majority of food 
contact surfaces leading its spoilage. In biofilm formation several microorganisms 
may be involved (Chmielewski and Frank, 2003). Earlier it was believed that bacteria 
exist as free floating (Plankton) in natural environment. Planktonic cells grow rapidly 
because they have unhindered access to nutrients.  So they are found to have high 
motility as will as susceptibility to environmental factors and antibiotics. But when 
there are some harsh conditions such scarcity of nutrients, bacterial growth become
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 Slow down due low metabolic rate.  In such condition bacteria become sessile 
(adhered to a surface or one another). Large  aggregates  are formed by the sessile 
bacteria (Watnick and Kolter, 2000). 
The architecture of biofilm consists of two main components i.e.  water 
channel for nutrients transport and a region  of densely packed cells having no 
prominent pores in it (Watnick and Kolter, 2000; Wimpenny et al., 2000). The 
microbial cells with in biofilms are arranged in way with significant different 
physiology and physical properties. Bacterial biofilm is less accessible to antibiotics 
and human immune system. Microorganisms that produce biofilm have increased 
capability to withstand and neutralize antimicrobial agents and result in prolonged 
treatment. Bacteria that form biofilm switch on  some genes that can initiate the 
expression  of stress genes which in turn  switch to tolerable/resistant phenotypes due 
changes in nutritional quality or parameters like temperature, cell density, pH and 
osmolarity (Fux et al., 2005). There is very complexity in biofilm structure; it is not 
only the binding/adherence of bacteria to a biological or inert surface. The biofilm 
water channels are when compared to system of circulations showed that biofilms are 
considered primitive multi-cellular organisms (Gilbert et al., 2001). The chemical 
composition of biofilm is not so simple. It is very complex in nature and comprised of 
various components such as microbial cells, extracellular polymeric matrices (EPS), 
proteins, lipids, DNA, RNA and enzymes  (shown in Table  2.1). In addition to these 
components, water is the major part of biofilm which is responsible for the in flow of 
nutrients inside to the biofilm matrix. These different components signify the biofilm 
integrity and making it resistant against various environmental factors (Vasudevan, 
2014).
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Figure 2.1: Diagram showing various components of bacterial biofilm. 
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2.3 BIOFILM FORMATION PROCESS 
Biofilm formation is a multi-step process in which the microorganisms 
undergo certain changes after adhering to a surface. Microorganisms which form 
biofilms are shown to elicit specific mechanisms. There are several steps in biofim 
formation which involves (a) attachment initially to a surface (b) formation of micro-
colony (c) three dimensional structure formation (d) biofilm formation, maturation 
and detachment (dispersal) (Costerton et al., 1999). 
Attachment: When a bacterium cell reaches near to some surface/support so close 
that its motion is very slow down, it make a reversible connection with the surface 
and /or already adhered other microbe to the surface.  For biofilm formation, a system 
of solid–liquid interface can provide an ideal environment for microorganism to 
attach and grow (e.g. blood, water) (Costerton et al., 1999). For most frequent 
attachment and biofilm formation rough, hydrophilic and coated surfaces will provide 
better environment. Increased attachment may also occur due to increase but not 
exceeding critical level in flow velocity, temperature of water or nutrients 
concentrations. Presence of locomotor structures on cell surfaces such as flagella, pili, 
fimbriae, proteins  or polysaccharides  are also important and may possibly provide an 
advantage in biofilm formation  when there are mixed community (Donlan, 2002). 
Micro-colony Formation: Micro-colony formation takes place after bacteria adhered 
to the physical surface/biological tissue and this binding then becomes stable which 
results in formation of micro-colony. Multiplication of bacteria started as a result of 
chemical signals which are emitted by bacterial cells. These signals are a means of 
communications among the bacterial cells involved in biofilm formation. The genetic 
mechanism of exopolysaccharide production is activated when intensity of the signal 
cross certain threshold level (Costerton et al., 1999). So by this way using such 
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chemical signal, the bacterial cell divisions take place within the embedded 
exopolysaccharide matrix, which finally result in micro-colony formation (McKenney 
et al., 1998). 
Three Dimensional Structure Formation and Maturation: After micro-colony 
formation stage of biofilm expression of certain biofilm related genes take place. 
These gene products are needed for the EPS which is the main structure material of 
biofilm. It is reported that bacterial attachment by itself can trigger formation of 
extracellular matrix. Matrix formation is followed by water-filled channels formation 
for transport of nutrients within the biofilm. Researcher have proposed that these 
water channels is like a circulatory systems, distributing different nutrients to and 
removing waste materials from the communities in the micro-colonies of the biofilm 
(Prakash et al., 2003). 
Detachment: After biofilm formation, it has been often noticed by the researchers 
that bacteria by itself leave the biofilms on regular basis. By doing this the bacteria 
can undergo rapid multiplication and dispersal. Detachment of plaktonic bacterial 
cells from the biofilm is a programmed detachment having a natural pattern 
(Costerton et al., 1999). Sometime occasionally due to some mechanical stress 
bacteria are detached from the colony into the surrounding. But in more cases some 
bacteria stop EPS production and are detached into environment. Dispersion of  
biofilm cells occur either by detachment of new formed cells from growing cells or 
removal as a result level of nutrient, dispersion of biofilm aggregates due flowing 
effects or quorum- sensing (Baselga et al., 1994). In case of P. aeruginosa biofilm, 
cells from the biofilm matrix are detached as a result of action of   an enzyme that 
causes digestion of alginate (Costerton et al., 1999). Phenotypic characters of 
organisms are apparently affected by the mode of biofilm dispersion. Dispersed cells 
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from the biofilm have the ability to retain certain properties of biofilm, such as 
antibiotic in-sensitivity. The cells that detach as a result of growth from biofilm may 
return quickly to the normal planktonic phenotype (Baselga et al., 1994). 
 
 
Figure 2.2: Figure describing process of biofilm formation (Hung and Henderson, 2008).  
Different events occurring during biofilm formation involves, (a) Initial surface attachment (b) 
micro-colony formation (c) formation of three dimensional structure (d) biofilm establishment 
and maturity and detachment (dispersal). 
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2.4 ANTIBIOTIC RESISTANCE IN BACTERIA 
 Emergence of antibiotic-resistant bacteria is increasing frequently and creating 
big problems and raising a lot of difficulties in treatment of infections. Global 
antibiotic resistance has been reported by several researchers. According to them the 
frequent inadequate usage of antimicrobials in livestock, humans and pets, and 
humans has been considered to increase the emergence of antibiotic resistant bacteria. 
This is considered for  emergence and spread of such a resistance in environment 
(Huang et al., 2011).  In last decade emergence of bacterial resistance has amplified in 
great frequency. Due to such a global emergence researchers are trying to control 
emergence of multi drug resistant (MDR) bacteria and devised phage applications 
(phage therapy) instead of frequent use of commercially available antibiotics. To 
control biofilm associated infections, applying phages is considered suitable due to 
less hazardous nature as  compare to toxic antibiotics (Hughes et al., 1998; Hanlon et 
al., 2001). In bacteria resistance is arising due to genetic mutations. Such mutations 
are transferred from one bacterium to other bacterial strains and eventfully lead to 
form strong antibiotic-resistant populations.  Human and animals are responsible for 
dissemination of antibiotics and their products into their natural environment. These  
antibiotics pose a selective pressure for maintaining resistance among microorganisms 
(Gadad et al.,  2004). It has been found that the bacteria (70 %) causing nasocomial 
infections have been found resistant to most commonly used antibiotics. There are 
some bacteria that are unresponsive to all approved antibiotics and  the severe  
infections caused by  such a bacteria are treated only by  potentially toxic drugs 
(Brown et al., 2006). Recently , severe infections  caused by CTX-M extended-
spectrum  β-lactamases (ESBLs)  is now frequently reported  from  different countries  
(Walsh et al., 2007). Klebsiella and E. coli species have been reported to show 
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resistance to the expanded-spectrum cephalosporins. Antibiotic resistance is now a  
widespread danger disseminating throughout the world (Pitout et al., 2004). The CDC 
has also reported about 95 % staphylococcal infections (nosocomial) showing no 
response to first line of antimicrobial treatment.  S. aureus, E. faecalis, A. baumanii, 
Klebsiella, P. aeruginosa and E. coli have been considered the most dangerous strains 
in Latin America. It is found that these bacterial strains are very less responsive to 
antibiotics and  indicating great problem to human population (Kutateladze and 
Adamia, 2008). 
2.5 BIOFILM FORMING BACTERIA  
Nearly  all (99.9 %) of microorganisms have the ability to form biofilm on a 
wide range of surfaces i.e. biological  and inert surfaces (Sekhar et al., 2009). When 
microorganisms bind to a surface they produce EPS, and forms biofilm. Biofilm 
posing a great problem for public health due to its resistant nature to antibiotics and 
disease associated with indwelling medical devices. It has been proven that 99.9 %  of 
bacteria are capable of producing biofilm on a wide variety of biotic and abiotic 
surfaces (Costerton et al., 1978).  It is found that H. influenza has the ability to form 
biofilm in  human body  and can escape from immune system of human  (Sekhar et 
al., 2009). Biofilm forming capability has been reported in large number of bacterial 
species such as P. aeruginosa, Stereptococcus epidermidis,  E. coli spp, S. Aureus,  
Pasteurella multocida, Salmonella and Streptococcus mutans (Miller and Bassler, 
2001; Parsek and Singh, 2003; Fux et al., 2005; Ma et al., 2009).  
Escherichia coli: is rod shaped Gram negative bacteria and is considered related to 
nasocomial and community infections such as urinary tract infections (UTIs), 
prostatitis. It has the ability to secret toxins, polysaccharide adhesins and can form 
biofilm. It can also form biofilm in-vitro (Naves et al., 2010). Among community-
Chapter 2                                                                                               Literature Review  
                                                                                                                                                                                                                                                                                                                                              
  27 
 
acquired illnesses, about 80 % to 90 % of all UTIs are caused by E. coli and 90 % of 
first episodes of UTI in children (Shapiro, 1992). Among the members of 
enterobacteriaceae, E. coli is of particular concern because it is the most common 
pathogen causing infections in humans. E. coli (resistant) strains are capable of 
transferring antibiotic resistance not only to other strains of E. coli but also to other 
bacterial species (Goossens, 2000). Thickness of E. coli biofilm may be of hundreds 
of microns and posing a difficulty in treatment with antibiotics due to presence of 
exopolymers (Surette and Bassler, 1998).  
Pseudomonas aeruginosa: is a Gram negative notorious opportunistic pathogen 
found along with other Pseudomonas species as part of normal flora of human skin 
(Larson et al., 2003; Mooij et al., 2007).  P. aeruginosa is a ubiquitous human 
pathogenic organism present everywhere, and can be isolated from different sources 
such as humans, plants and animals. It  can withstands the harsh environmental 
conditions  and persist in environmental and hospital settings (Lutz and Lee, 2011). 
It is an opportunistic pathogen causing infections in immune deficient patients 
(Bodey et al., 1983)  such as infections in patients with severe burn wounds (Holder, 
1993; McVay et al., 2007) and patients with  cystic fibrosis (Gallagher and Manoil, 
2001). It causes about 12 % of nasocomial infections such as urinary tract infections 
(UTIs), cystic fibrosis, showing strong association with high rate of mortality among 
patients (immune-compromised). In P. aeruginosa antibiotic resistance is considered 
due to resistected uptake and efflex, drug inactivation and changes in the targets are 
the three mechinisms employrd (Poole, 2001).  P. aeruginosa  has strong tendency to 
form biofilm (O'Toole et al., 1999) and  such a biofilm has been found to be partially 
responsible for the P. aeruginosa persistent infections (Costerton, 2001; Hall-
Stoodley et al., 2004). P. aeruginosa posing resistance to multiple antibiotics, even 
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including ciprofloxacin, that are commonly used to treat lung infections (Lyczak et 
al., 2002). 
Enterobacter cloacae:  a Gram positive bacteria causing a range of nasocomial 
infections in human i.e. lower respiratory tract infection, bacteremia, urinary tract 
infections, endo-carditis,  intra-abdominal infections,  septic arthritis, skin and soft 
tissue infections, osteomyelitis and ophthalmic infections (Kim et al., 2012). 
Enterobacter  causing nasocomial infections is most frequently isolated species and in 
recently has emerged as an important pathogenic bacteria  (Ma et al., 2005). 
Bloodstream infections which are responsible for morbidity and mortality in both 
developing and developed countries are caused by E. cloacae (Liu et al., 2004; Kim et 
al., 2012). It also causes biofilm associated infections such as UTIs and  biliary tract 
infections  (Fernandez-Baca et al., 2001). Enterabacter also has property of intrinsic 
resistance to certain antibiotics such as ampicillin and narrow-spectrum 
cephalosporins. It also showing high frequency of mutations to expanded-spectrum 
and broad-spectrum cephalosporins (Then, 1987). It also posses beta-lactamase and 
showing resistance to third generation cephalosporins (Pearl et al., 2008). 
Klebsiella pneumoniae: a Gram negative bacteria, frequently causing nasocomial 
infections, belong to the genus Klebsiella. K. pneumonie is very important species 
among genus Klebsiella and causing a considerable proportion of nasocomial 
infections such as urinary tract infections (UTI), pneumoniae, septicemias and soft 
tissue infections. It is transmitted through gastro-intestinal tract and the hospital 
personnel hands. Nasocomial infections outbreaks are caused by these bacteria 
(Podschun and Ullmann, 1998). K. pneumoniae infections are very devastating and 
having a mortality rate between 25 % and 60 % (Ellis, 1998). 
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Shigella dysenteriae: is a Gram negative bacterium causing severe human 
gastrointestinal infections. On the basis of serologic or biochemical reactions, Shigella 
has are four species. These species are S. dysenteriae, (serogroup A), S. flexneri 
(serogroup B), S. boydii (serogroup C) and S. sonnei (serogroup D) (Peleg et al., 
2013; Khan et al., 2014). Bacillary dysentery which is a major public health problem 
in many developing countries is caused by type 1 S. dysenteriae which usually leads 
to the most severe form of dysentery (Sreenivasan et al., 2013). It has been reported 
by Control of Diseases center (CDC) that S. dysenteriae is the third most common 
pathogen transmitted through food (Sims et al., 2011).  
2.6 BIOFILM DEVELOPING ON INDWELLING MEDICAL 
DEVICES 
Nearly all (99.9%) mico-organisms  have the ability to form biofilms on a 
wide range of surfaces i.e. living and  inert surfaces (Sekhar et al., 2009). There is a 
huge expenditure of $170 billion/year worldwide for production of bio-medical 
devices and tissue engineering related materials and with more than 5 million 
prosthetics implants each year. About 80 % of nasocomial infections are associated 
with implants or indwelling medical devices resulting up to 60 % of fatality rate in 
patents. Bacterial infections are very common on implants  including intravascular 
catheters, orthopaedic implants, ventricular assist devices, cardiac pacemakers, 
vascular prostheses, urinary catheters, contact lenses, ocular prostheses, prosthetic 
heart valves, intrauterine contraceptive devices and cerebrospinal fluid shunts (Bryers 
and Ratner, 2004). Biofilms that are formed due to mixing of exopolymers from 
different microorganisms are extremely resistant to heavy doses of antibiotics such as 
mixed cell line biofilm (Hendricks et al., 2000; Bryers and Ratner, 2004). It was 
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reported during a study on P. aeruginosa biofilm, in which 99 % of colonization was 
reduced due to surface coating as compare to control. Similarly it was proved in an 
another study that reduction of biofilm can also be achieved by using tetraglyme  (a 
glycol dimethyl ether) (Bryers and Ratner, 2004).  Biofilms have been developed in  
about 63 %  of needle connectors (NCs) and patients having blood stream infections 
(BSI)  are due to intravenous access lines and NCs (Elliott et al., 1997). According to 
CDC biofilm can be formed due to  central venous catheters (CVCs)  and NCs which 
can progresses up to blood stream infections (BSI) (Anaissie et al., 1995) 
2.7 BIOFILMS AND ANTIBIOTIC RESISTANCE 
Mechanisms of antibiotics and biocides resistance of biofilms are categorized 
into four classes which include (a) active molecule inactivation directly (b) altering 
body's sensitivity to target of action, (c) reduction of the drug concentration before 
reaching to the target site and (d) efflux systems. Biofilms antibiotic resistance level 
may vary among different sittings and the key factors responsible for this resistance 
may also differ. Regarding resistance, the primary evidence shows that conventional 
mechanisms are unable to explain the high resistance to antibacterial agents 
associated with biofilms, although this evidence cannot be ignored in resistance in the 
growth of adherent cells. So it is suggested that the resistance posed by the adhered 
bacteria or biofilms may have some intrinsic mechanisms and are responsible for 
conventional antibiotic resistance. At present there is no single accepted mechanism. 
Several mechanisms have been explored as responsible for this high resistance 
characteristic of biofilms. These mechanisms are (a) limited diffusion, (b) enzyme 
causing neutralizations, (c) heterogeneous  functions, (d) slow growth rate, (e) 
presence of persistent (non dividing) cells and (f) biofilm phenotype  such adaptive 
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mechanisms e.g. efflux pump and membrane alteration (Hogan and Kolter, 2002, 
Poole, 2002). 
2.7.1 Low Penetration of Antibiotics 
Diffusion of antibiotics can take place through the matrix of the biofilm. 
Diffusion or penetration of antibiotics to deeper layers of biofilm is affected by 
exopolysaccharide acting as a physical barrier. When molecules direct interact with 
this matrix, their transport to the interior is altered, resulting resistance to these 
antibiotics. This may also acts as a barrier for high molecular weight molecules 
having cytotoxic properties such as lysozyme and complement proteins. In liquid 
culture bacterial cells are readily exposed to antibiotics as compare to compact 
structure biofilm. Bacteria escape from biofilm that do not produce polysaccharide 
and are easily attack by immune system cells. Inactivation of antibiotic takes place 
when bind to biofilm matrix. Presence of exopolysaccharide (anionic in nature) matrix 
in P. aeruginosa explains slow penetration of fluoroquinolones and aminoglycosides 
(Gordon et al., 1988; Lewis, 2001; Mah and O’Toole, 2001). It is stated that in mixed 
culture of K. pneumoniae and P. aeruginosa biofilms penetration of chlorine does not 
go behind 20% while in case of S. epidermidis biofilms vancomycin reaches in to 
deeper but rifampin does not. Low penetration of antibiotic is not sufficient to explain 
the biofilm resistance, other mechanisms have been assumed that must be involved. 
This is also suggested recently that slow diffusion of antibiotics permit plenty of time 
to establish a protective response to stress (Mah and O'Toole, 2001). 
 
 
 
 
Chapter 2                                                                                               Literature Review  
                                                                                                                                                                                                                                                                                                                                              
  32 
 
2.7.2 Neutralization by Enzymes 
Antibiotics resistance in biofilm may be due to the presence of neutralizing 
enzymes which degrade or inactivate antibiotics. These enzymes are proteins which 
confer resistance by mechanisms such as hydrolysis, modification of antimicrobials 
by different biochemical reactions (Wright, 2005; Gallant et al., 2005). Accumulation 
of these enzymes occurs in the glycocalyx from the biofilm surface by action of the 
antibiotics. Neutralization by enzymes is enhanced by slow penetration of antibiotics 
and also antibiotics degradation into the biofilm. Overproduction of cephalosporinase 
AmpC enzymes is an important mechanism of resistance in cystic fibrosis posed by P. 
aeruginosa. This enzyme confers resistance to β-lactam in the presence of even much 
more concentration of carbapenems (Rojas and Del Valle, 2011). During a study 
when a filters impregnated with antibiotics was applied on K. pneumoniae biofilm 
(mutant cells beta-lactamases), in spite of good diffusion of antibiotic growth was 
observed, suggesting that there would be another mechanism of resistance which must 
be considered (Anderl et al., 2000). 
2.7.3 Heterogeneous Nature 
Studies performed on determination of microbial growth in biofilms by using 
a microelectrode with probes to direct measure oxygen concentration in different 
areas of the biofilms (Mah and O¨Toole 2001). It is reported that biofilms are 
heterogeneous both structurally and metabolically. In biofilms both aerobic and 
anaerobic processes occur simultaneously. So in responsiveness to antibiotics may be 
different in different areas of the biofilms. On surface of biofilm a high level of 
activity of antibiotics while inside the biofilms a slow or absent growth reduces the 
sensitivity of the cells to antimicrobials (Stewart and Franklin, 2008). Aerobic or 
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facultative anaerobic microbial populations within the different layers of the biofilm, 
enables us to understand the differences in susceptibility to treatment with antibiotics. 
Antibiotics response to the plaktonic forms is different from the adhered cells. Action 
of aminoglycosides is affected by limitation of oxygen and anaerobic growth of 
microorganisms, which is affected by the presence of oxygen and pH gradients 
(Wimpenny, 2000). 
2.7.4 Cells Slow Growth Rate 
 Slow growth of microorganisms occurs due to limited availability of nutrients 
which confer resistance to antibiotics. Within biofilm there is a gradient of nutrients 
resulting in metabolically active cell (surface layer or on the periphery) and inactive 
cells (within its interior) (Brown and Allison, 1988). Bacterial cells are attack by both 
penicillin and ampicillin only when they are growing. Some other antibiotics that 
attack cells in stationary are as β-lactams, aminoglycosides, cephalosporins and 
fluoroquinolones (Costerton et al., 1999). So due to slow growth resistance has been 
determined in different bacterial strains such as resistance to cetrimide on E. coli, 
piperacillin and tobramycin in P. aeruginosa and ciprofloxacin on S. epidermidis. It 
has been shown that this resistance was due to slow growth (Donlan and Costerton, 
2002). There are some natural peptides produce during host innate immune response 
act as antibacterial providing protection to the body (Rivera, 2001). A peptide named 
polymyxin E, effective in treating cancer patient’s biofilms and cystic fibrosis by P. 
aeruginosa who are showing no response to drugs (Hachem et al., 2007). In Cystic 
fibrosis patients, using ciprofloxacin and tetracycline can clear active growing cells 
and it is suggested that a combination of antibiotic colistin with other  two antibiotics 
(ciprofloxacin and tetracycline) will be very effective in clearing P. aeruginosa (Pamp 
et al., 2008). 
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2.7.5 Existence of Persistent Cells 
After an antibiotics treatment of biofilm, a very small number of bacterial cells 
remain viable are called persistent cells. These cells may or not give this resistance to 
their progeny once the pressure is removed. The persistent cells stop replication for 
time being for the survival of the community and their adaptive mechanism is not 
related to the mechanism followed by the cells during stress such as environmental 
damage. Persistent cells work for survival and bear multiple doses of antibiotics that 
cause clearing of normal cells. When cell density reached the highest number in the 
stationary phase, persistent cells increase in number indicting that their main role in 
survival (Lewis, 2008). There are certain evidence for the presence of persistent cells 
in biofilm, the main evidence of existence in biofilms are: a) there is existence of a 
biphasic dimension in biofilms which means that large number of cells population is 
attacked while the rest of population is not attacked (resistant) even with a extensive 
antibiotics treatment, b) persistence gene description  that function as a circuits of 
regulation, c) bacteriostatic antibiotics contribute to growth of persistent cells and 
biofilm preservation by causing inhibition of growth of sensitive cells and d) 
reshaping of biofilm into original form when the antibiotics therapy is withdrawn 
(Mendoza, 2004)   
2.7.6 Biofilm Phenotype 
 There are two important factors in physiology of planktonic cells reaching 
stage of  stationary phase that are starvation caused by nutrients and in a limited space 
obtaining a high cell density. Biofilm formation describes the bacterial growth natural 
phase showing more production of metabolite not needed by the cell for growth 
(secondary metabolites) such as antibiotics, pigments and other molecules. These 
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metabolites function as signaling molecules in formation of biofilms (Estela et al, 
2011). Biofilm phenotype is a community cells that confers no response to antibiotics 
treatment and characteristic phenotype is formed. These characteristics have proposed 
the presence of specific genes, however, performing DNA microarrays and gene 
expression for Bacillus subtilis biofilms  gene which shows 6 % difference compared 
to their planktonic culture cells and only 1 %  difference is shown in P. aeruginosa. 
However at present time, this differential gene expression has not been proven fruitful 
for describing this mechanism (Fux et al., 2005). 
2.7.7 Efflux Pumps 
Efflux pumps are protein structures, either express constitutively or 
intermittently. These pumps may have substrate specificity. Similar compounds can 
be transported by these pumps that may be involved in multidrug resistance (MDR) 
(Grkovic et al., 2002; Sanchez-Suarez et al., 2006). Efflux pumps inside the bacteria 
in the periplasmic area, antagonized accumulation of antibiotics that are resistant to 
different groups of antibiotics including macrolides, tetracyclines, fluoroquinolones, 
β-lactam and reducing these antibiotics concentration at sub-toxic level (Van 
Bambeke et al., 2003). Five families of efflux transporters have been identified in 
prokaryotes (Webber and Piddock, 2003). Over expression of the efflux pumps have 
been considered to be responsible for antibiotic resistance in P. aeruginosa biofilms 
(De Kievit et al., 2001).  
2.7.8 Membrane Proteins Alterations 
Permeability of outer membrane is very important for the antibiotic diffusion 
that permits diffusion to the periplasmic space through different routes. Outer 
membrane channel proteins (porins) present in Gram-negative bacteria have a key 
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role in transportation of hydrophilic molecules from the external environment to the 
periplasmic space.  Porins encoding genes can mutate and result in production of 
nonfunctional or altered proteins expression. These mutant porins, have low 
permeability for the passage of hydrophobic molecules (Hancock, 1997).  Porin OprD 
in P. aeruginosa is responsible for resistance to imipenem causing three-dimensional 
disturbance of imipenem molecule. The differential expression of porin coding genes 
occur in biofilm leading to antibiotic resistance. Increased expression of ompC and 
three other genes (osmotically regulated) occur when the bacteria grow as biofilms 
(Mah and O’Toole, 2001). 
2.7.9 Phase Variation 
A key role is played by diverse phenotype within biofilms and is largely 
responsible for the recalcitrance of infections caused by biofilms. Authors have 
reported this phenomenon for many genera and species which are exemplified by 
Staphylococcus and Pseudomonas genus, and some species of Enterobacteriaceae 
(Costerton et al., 1999). Biofilms have the capability to develop bacterial 
subpopulation to switch to the quiescent state as small-colony known small colony 
variants (SCVs). These variants cells have very less susceptibility to growth phase 
dependent killing of antibiotics. Also have a defective catalase activity which 
interferes with oxidative metabolism (Rusthoven al., 1979; Neut et al., 2007). 
Detectable colonial morphological changes are caused by SCVs in biofilms leading to 
characteristics of increased adherence, autoaggregation, increased hydrophobicity and 
low level motility. It can also withstand wide range of harsh environmental stress 
conditions so that this mechanism is considered a survival mechanism for biofilms. 
Phase variation was considered to the process of cellular internal rearrangement but 
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recently it is consider that phase variation occur due to genetic elements interaction 
(Chia et al., 1999).  
 
 
Figure 2.3: Antibiotic resistance associate to biofilms. Figure showing key mechanisms 
involved in antibiotic resistance such as enzyme causing neutralizations, presence of 
persistent (non dividing) cells and biofilm phenotype  (Castrillon et al., 2012). 
2.8 BACTERIOPHAGES AND BIOFILM CONTROL 
Roy et al. (1993) used phages to treated L. monocytogenes biofilms with over 
10
8
 phages/ml. Using stainless steel or polypropylene surfaces, biofilms were formed 
for one hour with suitable number of bacterial cells followed by air drying. They only 
used phages for eradication of biofilms. They observed 2 to 4-log reductions in 
biofilms in about 1 hour. This treatment would be more than enough to reduce or 
control low level of bacterial food contamination. Bacteria removal over can be 
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increased by combining phages with a quaternary ammonium compound (QUAT) as 
compare to QUAT alone. 
Doolittle et al. (1995) studied the effect of phage T4 on E. coli biofilms. They 
used polyvinylchloride surface for biofilm formation. They used MOI of 0.06 to 0.74. 
They observed a 6-log reduction in bacterial densities in five hours. They did not 
extend their study to find complete eradication of E. coli biofilm. 
Doolittle et al. (1996a) have described the phage treatment for E. coli biofilm. 
They used fluorescently labeled phages and observed microscopically. They treated E. 
coli biofilm with phage T4 and observed initially increase phage adsorption. More 
and more absorbance rate was observed when phages were applied in larger quantity. 
During this study phage penetration to biofilms was observed. Phage infected 
bacterial cells become large in size having white dots like spheroplast which indicated 
the possible cell lysis. 
Doolittle et al. (1996b) also studied P. aeruginosa biofilm eradication by 
using fluorescently labeled bacteriophages. They observed that only upper layers of 
the biofilms were affected and no good penetration was observed. They did not find 
actual reason for phage penetration failure. This failure may be due phage tendency to 
adsorb to nearer permissive bacteria or EPS blocks phage movement downward into 
the biofilm. 
Hibma et al. (1997) studied prevention of biofilm through phages. They used 
phages to eradicate already established biofilms formed by L. monocytogenes. They 
used a passive treatment (10
10
 phages/ml) of phages for six hours and observed 3-log 
reductions in bacterial population. Authors suggest that using more phages results 
better phage adsorption and hence can result in more biofilm eradication. 
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Hughes et al. (1998a) studied the effect of phage on already established 
biofilm of Enterobacter agglomerans formed on polyvinylchloride. They observed 
the disruption of biofilm due to a degradation of EPS and lysis of bacteria. After 24 
hours, biofilms biomass was measured which was about 10
6
 viable cell per cm
2
. Than 
an appropriate number of phages (20 ml = >10
9
 phages/ml) were applied to the 
biofilm. A 2-log reduction in bacterial viable counts was recorded in the first half an 
hour of treatment. Post application (2-5 hours) of phages, more then 3-log reductions 
in bacterial biofilm was recorded in terms of bacterial viable cell counts. Hughes et al. 
(1998b) in other experiments reported impressive 2-log reductions in bacterial 
biofilms. It was observed over a short period of (about three hours) when phages were 
applied to biofilms consisting of phage-resistant bacteria.  
Corbin et al. (2001) studied the effect of phage T4 in controlling E. coli 
biofilms. They have claimed a lot in this study but the supporting data presented here 
is very less. After three hours of phage treatment, they reported bacterial densities 
reduction of about one and a half log as compare a control culture without a phage.  
Hanlon et al. (2001) studied the application of phages on twenty days old P. 
aeruginosa biofilms. This study is important for the fact that the EPS is unable to stop 
or prevent phage infections. They reported that purified phage particles (polyethylene 
glycol precipitated) have the ability to lesser the EPS viscosity, specifically, alginate, 
i.e. which may be due to phage depolymerase enzyme activity. The important factor 
of this study is the addition of 10-fold higher phage densities, resulted an 
approximately 10-fold greater bacterial lysis after treatment of 24 hours. However, 
during this study they observed a total of 2- log reduction in biofilm biomass. 
Wood et al. (2001) have described in-vitro catheter model for biofilm study. 
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They describe the application of bacteriophage against S. epidermidis biofilm and 
have reported some success in biofilm eradication. They have obtained a complete 
removal of biofilm in a single trial. 
Tait et al. (2002) have described the treatment of a dual-species biofilm of E. 
cloacae with bacteriophages. They have done biofilm treatment by using a 
combination of purified EPS depolymerase and various chemical disinfectants. 
However, smaller consistent difference is observed between the different doses, with 
all providing 3 to 4-log reductions in bacterial cells densities whether in single or 
dual-species biofilms. In addition, indicated ratios are 0.1, 0.01, and 0.001 phages to 
bacteria, implying that active treatment was relied upon; though there is no 
exploration of phage population dynamics other than those phages were incubated 
with biofilms for 24 hours. They have observed more biofilm removal with the phage 
that displayed both lytic and EPS depolymerase activity. In a dual-species biofilm, 
phage impact was negative even on the non-susceptible bacterium implying a role for 
EPS in the stability of both susceptible and not-susceptible bacteria and very less 
reduction was observed 10
4
 to 10
5 
bacteria/cm
2
. But in another study where phage 
cocktail (combination of three phages) was used resulted in about approximately total 
eradication of single species E. agglomerans biofilm. 
 Sillankorva et al. (2004) performed phage experiments on plaktonic form of 
bacteria. Firstly, they determined optimum temperature for phage treatment and then 
treated broth-suspended P. fluorescens biofilms with a phage. They observed about 
one-log reduction on bacterial planktonic population. 
Sharma et al. (2005) have studied the application of phage and other chemical 
agents (cleanser and disinfectant solutions) to kill E. coli O157:H7 biofilms formed 
on surface of stainless steel plate. They performed at cold temperature (4 °C) using a 
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phage titer of about   (10
8
 phages/ml). More than one log reduction in bacterial 
density was observed with in single day as compare to compare to five or more logs 
for alkaline cleanser. Phage potentiality can be possibly enhanced by using higher 
phage doses making them able to absorb and lyse bacteria under the treatment 
conditions. 
Curtin et al. (2006) used phage for biofim treatment. They developed biofilms 
on silicone catheters (hydrogel-coated) which were pretreated with the lytic S. 
epidermidis phage 456 for 1 hour at 37 °C before biofilm formation. Phage treatment 
(24 h) of S. epidermidis biofilm formed on silicone catheters effectively reduced 
viable biofilm formation. This study suggests the efficacy of phage for eradicating or 
inhibiting catheter biofilm formation. 
Moons et al. (2006) have studied the efficacy of phage T7 on E. coli biofilms. 
Phage T7 was applied for treatment E. coli biofilm for one 1 hour at a titer of 10
10
 per 
ml and about 2-log reductions in bacterial biofilm cells count was observed.  
Cerca et al. (2007) passively treated 24 hour S. epidermidis biofilms with 
approximately 10
8
 per ml of phage K.  They observed about one log reduction in 
bacterial population which was determined via crystal violet staining. The killing 
pattern of disaggregated biofilm bacterial cells or re-suspended bacteria was similar 
that of stationary phase or planktonic (broth culture) bacteria. During this study phage 
K showed low killing of both bacterial planktonic cells and biofilm-grown cells  
Del Pozzo et al. (2007) studied the effect of phages on S. aureus biofilm in-
vitro and obtained about one log reduction. They observed a biofilm removal of about 
79.4 % and as determined via crystal violet (CV) staining procedure. Vancomycin 
therapy gave about 20 % of biofilm density reduction as compare to phage. They used 
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phage densities of only 10
6 
to 10
7
 per mL final concentration. It is likely that the 
protocol relied upon active treatment.  
Lu and Collins (2007) studied biofilm removal by using an engineered phage. 
They constructed a phage T7 by genetic engineering to express a soluble enzyme. 
This enzyme was an EPS depolymerase not normally found in phage genome. The 
doubly engineered T7 phage reduced biofilms 4.5 logs as compare to both wild-type 
T7 phage as well as a control (phage untreated) of biofilm. The engineered phage T7 
was able to reduce bacterial biofilm about 2-log while the doubly engineered phage 
has the ability to both infect the E. coli strain as well degrade the EPS reducing  
density of biofilm to 2-log. So they have shown that the engineered phage have shown 
greater potential to eradicate biofilm as compare to wild type phage. 
Knezevic and Petrovic (2008) used phage treatment to control P. aeruginosa 
biofilm in addition to the prevention experiments i.e., in which quantification of 
biofilm was done using standard crystal violet (CV) staining procedure. When biofilm 
was initiated using low number of bacteria, substantial biofilm clearing was achieved 
by implying active treatment of phage with low doses which were capable of 
providing substantial biofilm clearing. 
Azeredo et al. (2008) stated that spontaneous biofilm formation occurs on both 
non-living and biological surfaces and this biofilm formation is the survival 
mechanism of bacterial community. Biofilms in humans can give rise to a number of 
infections, in which most of them are acquired from medical devices. Resistance to 
antibiotics and host defense system is major problem posed by biofilm. So there is a 
very urgent need to develop alternate strategies to prevent and control bacterial 
biofilm-associated with a large number of clinical infections. Several other authors 
have reported that phages have the ability to infect bacterial cells in biofilm. Phages 
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have also the ability to induce the production of depolymerases. It can penetrate the 
inner layer of biofilms by degrading the EPS matrix. Researchers have performed 
practices on biofilms found in hospitals sittings (clinical set up). Various 
apparatus/devices associated biofilms can possibly be prevented (controlled) by the 
surface application or the impregnation of device surface with a phage solution 
(filtrate). To control P. aeruginosa biofilms in cystic fibrosis patients, polysaccharide 
laser (phage enzyme) is used which is another promising approach by aerosol 
administration. 
Sillankorva et al. (2008a) studied the application of phages on P. fluorescens 
biofilms. They formed biofilms on glass surface and bacterial densities measured 
were approximately 10
6
/cm
2
. They used relatively high phage densities initially. 
When they used a high phage density by jumping 5-fold from lower to higher resulted 
in 2 to 3- fold biofilm reductions. These results could be considered as strong 
evidence for the potential utility of phages for passive phage treatment application. 
An MOI of 0.7 was required to reduce bacterial cell density by one-half (1/2). They 
also performed phage biofilm removal study and hybrid passive active treatments 
were done. They observed high bacterial removal by using high phage densities 
implying passive phase of treatment and small bacterial depletion was observed 
during active phase. Interestingly, the bacterial cells removed during early stages of 
phage treatment of biofilm were the same for bacterial cell count removed from the 
very mature biofilm. They reported poor penetration of phage into the interior of 
biofilms. 
Sillankorva et al. (2008b) used steeliness steel plate for bacterial biofilm 
formation. They used a different phage, phiIBB-PF7, to eradicate P. fluorescens 
biofilms. They applied a phage titer of 10
7 
CFU per ml for biofilm treatment. So 
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relying on active treatment, a good reduction in bacterial cell numbers was observed 
ranging from 1 to 5-logs.  
Donlan (2009) states that bacterial biofilm is infectious in nature and can 
results nosocomal infections. Bacterial viruses (Bacteriophages) have been used for 
treatment of human diseases and researchers are interested to use phages for bacterial 
biofilms control. Propagation of phages occurs in direct correlation to bacterial hosts 
and many phages have the ability to produce depolymerases that destroy bacterial 
biofilm. But in addition to it there are certain drawbacks associated with phage 
therapy. These include narrow host range of phages, development of bacterial 
resistance to phage, incorporation of phage virulence genes to bacterial genome. 
Immune system may also render phage inactive. They suggest that cocktail of phages 
or engineered phages can provide best way to remove these issues and the virulent 
(Lytic) phages can form a new group of anti-biofilm agents. 
Verma et al. (2009) used a combination of phage and antibiotic for the 
eradication of bacterial biofilms.  For treatment of K. pneumoniae biofilm, phage and 
the antibiotic (ciprofloxacin) were applied. Phage treatment reduced the biofilm to 6-
log which was the same for combination therapy as well. Total eradication of biofilm 
was not achieved. One notable factor of combination therapy was the inhibition of 
phage- resistant bacteria. It was also effective in inhibiting those bacteria which were 
not seemed to be very much involved in biofilm formation.  They have used phage 
with MOI of 1 that indicated effective removal of biofilm. 
   Fu et al. (2010) have found the inhibitory effect of phages on P. 
aeruginosa biofilm formation. Catheters coated with hydrogel were exposed to a suitable 
suspension of phage M4 for 2 hours at 37 °C before bacterial inoculation. The mean 
viable biofilm count on untreated catheters was 6.87-log CFU after 24 h while catheters  
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Ryan et al. (2012) have stated the significance of phage for the control of 
extremely antibiotic resistant infectious bacterial biofilms. They have described the 
synergy between bacteriophage T4 and cefotaxime (antibiotic) using plaque assay 
technique for eradication of in-vitro removal of E. coli 11303 biofilms. They have 
explained the synergic effect that the antibiotic in low concentration results the 
production of host bacteria. Increasing cefotaxime from sub-lethal concentrations 
resulted in an increase plaque size and phage titer. Combinations (phage and 
cefotaxime) also amazingly increased removal of bacterial biofilms as compare to 
with cefotaxime alone. The addition of 10
4
 PFU/ml and 10
7
 PFU/ml phage titers 
reduced E. coli biofilms from 256 to 128 and 32 μg /ml, respectively. However, 
further study is required to confirm combination (phage and cefotaxime). This study 
demonstrates that the synergy between phage and antibiotics can efficiently improve 
biofilm control in-vitro. 
Sillankorva et al. (2012) state that bacteriophages  specifically infect bacteria, 
causing cell disruption and therefore can be apply as a efficient agent for bacterial 
control. This study has demonstrated the phage potential to control bacterial biofilms. 
Phages can get inside the extracellular matrix and can remove 90 % of biofilm 
biomass even in old biofilms. However several factors such as biofilm components, 
slow bacterial growth and emergence of resistant phenotype bacterial cells can slow 
down phage action on biofilms. Theoretically, a rapid infection of biofilm should take 
place due to closeness of bacterial cells in biofilm and hence enhance phage 
replication as compare to suspended bacterial cells.  But on the other hand the biofilm 
age, growth mode, structure, composition and physiology may extend some hindrance 
to biofilm infection. 
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Keary et al. (2013) stated that viruses those are specific for bacterial cells 
infections are called bacteriophages. These were discovered in the second decade of 
nineteen century. After its discovery, the concept of phage therapy was introduced, 
which involves phage application for the eradication of harmful (pathogenic) bacteria. 
Early human trials results were made problematic due to lack of understanding 
regarding phage biology, poor experimental design and in some cases a lack of having 
knowledge about actual causative agent of diseases. And also wide availability of 
antibiotics in 1940s replaced bacteriophages as an antibacterial. However, due to 
frequent emergence of antibiotic resistance in harmful (pathogenic) bacteria in recent 
decades, it is now widely recognized that there is an urgent need to explore novel 
alternative strategies for control of bacterial diseases. So due to such a high antibiotic 
resistance and having good knowledge of phage biology, concept of phage 
applications for bacterial disease treatment and control have been reconsidered.    
Harper et al. (2014) stated that those viruses which grow on bacteria are called 
bacteriophages. All lytic phages have the ability to destroy their host bacteria. 
However some of them are temperate phages which insert their DNA into bacterial 
chromosome and act as provirus.  Only lytic phages have therapeutic applications. 
Killing of the bacterial cell results in the production of the next generation of phages. 
This unique character permit localized propagation of a phages make it suitable for 
therapeutic potential and host bacterial cells are present nearby. These phages also 
have the ability to kill bacteria living within biofilms that are very resistant to the 
conventional antibiotics. Since their discovery in 1915, phages have been identified as 
agent having ability to cure bacterial disease. Due to emergence of resistance to 
antibiotics, interest in this area has revived and phage therapeutics clinical trials 
results are now being reported. 
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Schmerer et al. (2014) stated that phages are used to treat bacterial infections 
and contaminations. A combination of phages is used at once as a cocktail. Using two 
or more phages to kill same bacterium, better killing is achieved as compare to single 
phage. This study explains synergy in which one phage enhances adsorption by 
another phage and presents first evidence of synergy from an experimental system of 
two phages and a mucoid E. coli host. The synergy seems to be arising from tail spike 
enzyme produced by one of the phages. They have done mathematical modeling and 
simulations to understand the dynamics of synergy and the enhanced degree of 
possible bacterial control. The models and observations support each other and 
indicate that synergy (combination) may be more applicable. 
Jamal et al. (2015) have described application of phage Z to control MDR K.  
pneumoniae in plaktonic form as well as biofilm. They state that biofilms are 
associated with a large number of human infections. They have isolated and 
characterized a bacteriophage Z and have investigated its activity against MDR K.  
pneumoniae planktonic form as well as biofilm. Phage Z efficacy was tested against 
bacterial planktonic form and biofilm. Considerable reductions of 2-fold and 3-fold 
were observed on 24 h and 48 h biofilms, respectively. 
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Chapter 3 
MATERIALS AND METHODS 
3.1 SAMPLING 
Sterile bottles (250 mL each) were used to collect samples from waste water 
channels, waste water treating plants, streams, lakes, rivers and springs in various 
localities (urban and rural) of Pakistan. From one particular location more than one 
sample was collected (Table 3.1). Samples were stored at 4 °C for processing. 
Table 3.1: Cities, localities and number of water samples collected. 
S:# City Locality/Area  No. of sample 
1 Rawalpindi Nasirabad, Qasimabad, Pirwadhi mour, 
Bakramandai, Dhamyal, Dhoksaida, Golra 
mour,  BaBa Gauhar, Mandi mor, Gulshan 
Colony, Wapda Colony, Nala lai,  New 
Bokra 
 
 60 
2 Islamabad Waste water treatment plant, 
Waste water channel near Shifa 
International Hospital, 
Waste water channel at G-10 
 
 40 
3 Lahore Green town, Township,  
Chungi , Amarsadhu 
 
 10 
4 Mardan College Chowk, Bakhshali, Katlang 
 
 20 
5 Peshawar Canal Water Pawaka/ Sewage water 
University Town, Haji Camp 
 
 10 
6 Swabi Shah Mansoor, Panjpir  06 
7 Dir Lower Gumbat, Amlookdara, Ziarat Talash, 
Timergara, Sarai, Shamshi Khan, Macho, 
Chikdara, Batkhela, Badwan, Ouch, 
Bandagai, 
 50 
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3.2 BACTERIAL SAMPLING  
A total of 30 different bacterial strains including Escherichia coli, 
Pseudomonas aerugonisa, Enterobacter cloacae, Kliebsilla pneumoniae and Shigella 
dysentery were collected during March, 2011 to September, 2011 from Railway 
General Hospital (RGH), Rawalpindi, Pakistan Institute of Medical Sciences (PIMS) 
and District Headquarter Hospital, Timergara, Pakistan. Bacteria were cultured and 
sub-cultured. Glycerol stocks of the bacterial strains were prepared and stored at -80 
o
C for the future use.  
3.3 SELECTION OF BACTERIAL STRAINS  
 Out of thirty (30) bacterial strains only five (5) were selected whom showed 
good tendency for biofilm formation. For this selection the bacterial strains were 
subjected to biofilm formation by using 96-well plate method. This method is derived 
from a well used method described by Christensen (1985). On day first each 
bacterium of interest was cultured in a culture tube (3–5 mL) and was grown up to 
stationary phase. On day second the stationary phase bacterial culture is 1:100 times 
diluted in Lb media. 9 wells out of 96- fresh well plate that were not previously 
treated with tissue culture were selected for dropping approximately 100 mL of 
diluted bacterial culture. Plate is covered with its lid and incubates at 37 °C for 48 h in 
static incubators. On day fourth the planktonic bacterial cells and culture media are 
removed by pipetted into a collection container containing 10 % bleach solution. Each 
well was washed by pipetted out distilled water in to wells and out into a collecting 
container containing 10 % bleach. This step was repeated three times. To each well 
125 μL of crystal violet solution (1 %) was added. The adhered cells were stained at at 
room temperature for 10 – 20 min. The crystal violet solution was pipetted out and in 
to the collecting container containing 10 % bleach solution. Remaining crystal violet 
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solution was washed by palpating in 200 μL water into each well and pipetting out 
into collection container containing 10 % bleach solution. This step was repeated at 
least four times. After washing crystal violet solution, 200 μL of dimethyl sulfoxide 
(DMSO) was added into each stained well. The in and out practice of pipetting briefly 
mixed the contents of each well before the addition of 125 μL crystal violet solution 
in each well of fresh optically clear flat bottom 96-well plate. By using ELISA plate 
reader, optical density (OD) was measure of each sample at 500-600 nm. 
3.4 BACTERIAL IDENTIFICATION 
 For identification of different bacterial strains, a single colony from a 
petriplate having bacterial culture was picked up and grown in a test tube containing 
Luria Broth (LB). The inoculated bacterial colony was constantly shake and kept at 37 
°C for the whole night. It was further propagated after 24 hour for identification. The 
LB media consisted of 10 g NaCl (Scharlu), 5.0 g Yeast extract (Uni chem.) 10 g 
Tryptone (Oxoid) per 1000 mL distilled water (dH2O).  
3.4.1 Morphological Characterization  
3.4.1.1 Gram staining method 
A single colony among different colonies in a nutrient agar plate was selected 
and was picked up with the help of an inoculating loop. It was then smeared on a glass 
plate and fixed by gentle heating. Crystal violet (CV) staining for one minute was 
applied on the smear before washing with water. Now a few drops of Gram’s Iodine 
was added to act as mordant for one minute and then the slide was flooded with tap 
water. Ethanol (95 %) was then applied as decolorizing agent for a few seconds to 
remove the primary stain. After washing with water safranin was added as counter 
stain and allowed to stain for 1 minute. The slides water washed and air dried. The 
glass slides were observed under light microscope with high power objective (100 X) 
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by using immersion oil (Merchant and Packer, 1967). 
3.4.2. Molecular Identification 
3.4.2.1 Extraction of DNA 
Bacterial DNA was  extracted by ZR Fungal/Bacterial DNA isolation kit. A 
3-5 mL of overnight bacterial culture was pellet down by cenifugation and lysis 
solution of 750 μL was added to the tube. The tube was protected in a bead beater 
fitted and processed at 1400 rpm for 6 min. The ZR Bashing Bead lysis tube was 
centrifuged at 12,000 rpm for 1 min. About 600 μL supernatant was passed through a 
filter (Zymo Spin) in a fresh collection tube and processed at 10,000 rpm for 1.5 min. 
From the above step filtrate was mixed with about 1200 μL of bacterial DNA binding 
buffer in collection. Then the mixture (900 μL) was introduced into to a column 
(Zymo Spin) in a collection tube and centrifugation was performed at 12,000 rpm for 
1.5 min.  The flow was discarded from the collection tube and the above step was 
repeated. Then 300 μL DNA Pre-Wash Buffer was introduced into a column and was 
put in a fresh tube (collection) and centrifugation was done at 12,000 rpm for 1.5 min. 
Then 600 μL bacterial DNA Wash Buffer (WB) was added into to the column and 
centrifugation was performed at 14,000 rpm for 1.5 min. Then the column  was put in 
a clean eppendorf tube (1.5 mL) and about 200 μL DNA elution buffer (EB) was 
directly added to the column matrix for centrifugation at 12,000 rpm for 30 s. The 
very pure bacterial DNA was noticed on 0.8 % agarose gel and was stored at -20 °C. 
3.4.2.2 Bacterial Strains Identification by Ribotyping 
The amplification and sequencing of 16S rRNA gene revealed the bacterial 
strain. Escherichia coli, Pseudomonas aeroginosa and Kliebsilla pneumoniae 
genomic DNA were isolated using kit as described by manufacturer (Cat No D6005). 
The bacterial 16S rRNA was amplified by Polymerase Chain Reaction (PCR) using 
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universal bacterial 16S rRNA primers (RS-1; 5’-AAACTCAAATGAATTGACGG- 
3’, RS-3; 5’-ACGGGCGGTGTGTAC-3’).  
3.4.2.3 Polymerase Chain Reaction 
  The  PCR mixture  (25 µL)  contained;  PCR  buffer  (1X) 2.5 µL,  MgCl2 
(2.5 mM) 1.5 µL , 4 dNTPs (0.2 mM) 1.5 µL , 2 primers (RS-1and RS-3, 20 pmole 
each) 1 µL each,  Taq  polymerase (1U),  template DNA  (3 μL)  and nuclease free 
water  (14.25 μL). Reaction mixture was placed in thermal cycler machine (Swift 
MaxPro Singaporer). Amplification was done according to Haq et al., (2012) 
protocol.  DNA amplification was performed by in accordance with the following 
thermal cycler profile (Figure 3.1). 
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Figure 3.1: Steps of polymerase chain reaction (PCR).   
3.3.2.4 Purification of PCR Product  
Gel extraction was done to isolate desired intact DNA fragment from gel 
(agarose) following electrophoresis by using gel extraction kit (Invitrogen™, 
Carlsbad, USA). Following steps were taken to obtain purified DNA. Heat block was 
equilibrated to 65 °C. Gel was placed on UV Transilluminator (Biometra, Goettingen, 
Germany) to cut the area of the gel containing DNA fragment and to minimize the 
amount of agarose surrounding DNA fragment using a clean, sharp blade. Gel slice 
was weighed; put in 1.5 mL microfuge tube (Axygen
®
, California, USA) and gel 
solubilization buffer (GS1) was added at ratio of 3 mL per mg of the gel. Eppendorf 
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microfuge tube was incubated at 50 °C in a incubator (Memment, Schwabach, 
Germany). Gel dissolution was ensured by mixing after every 3 minutes. Additional 
incubation for 5 min was done after complete dissolution of gel slice. Inside the wash 
tube, a quick gel extraction column was placed while the dissolved gel mixture with 
DNA was loaded onto the column for centrifugation at 12,000 rpm for 1 min using 
microcentrifuge (spectrafuge 24 D Labnet, Edison, New Jersey, USA). After 
discarding the  Flow through the column was placed back into the wash tube. The 
wash buffer (W9) was added to the column. The column was kept at room 
temperature for 6 min and centrifuged at 12,000 rpm for 1 min. The flow through was 
discarded. Centrifugation at 12,000 rpm was again repeated residual buffer was 
removed. Afterwards column was placed into a 1.5 mL recovery tube and 50 µL 
warm (65-70 C) autoclaved water was added to the center of cartridge. Final 
incubation was performed at room temperature for 1 minute and then centrifugation at 
12,000 rpm for 5 min was performed to get purified DNA in the recovery tube. 
3.4.2.5 DNA Sequencing  
  PCR Products purified by gel extraction kit were subjected to sequencing by 
CEQ 8000 Genetic Analysis System (Beckman Coulter, USA) using both forward 
(RS-1) as well as reverse primers (RS-3). The DNA sequences were subjected to 
BLAST alignment and were submitted to NCBI for Accession number acquisition. 
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3.5 ANTIBIOTIC SENSITIVITY OF THE CLINICAL BACTERIAL 
STRAINS 
 3.6 PHAGE ISOLATION, AMPLIFICATION AND TITRATION  
Sampling of waste water from different regions of Pakistan was performed. 
Five bacteriophages were identified and characterized during the period of May and 
September (2011). For phage isolation previously established methodology was used 
with some modifications (Jamalludeen et al., 2007). Luria Bertani (LB) media was 
used for culturing bacteria at 37 °C for 24 h. Initially, centrifugation of 100 mL waste 
water was performed (Centrifuge 5810R, Eppendorf Germany) to remove the 
impurities (suspended particles and algae) and then aseptically transferred into 500 
mL sterile flask. The mixture of twenty (20) mL of waste water, 40 mL of LB 
supplemented with MgSO4 (at 10 mM final concentration, and 20 mL of a bacterial 
culture  (OD = 1.00) were aseptically added into a flask prior to incubation at 37 °C  
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along with continuous shaking (120 rpm) for 16 h. The whole mixture was again 
centrifuged at12,000 rpm for 20 min. The supernatant was filtered through a 
membrane syringe filter (Fisher Scientific) (0.45 μm) and amassed in a fresh sterile 
tube. The supernatant was checked for its activity by spot assay. To do this  a bacterial 
lawn was prepared on nutrient ager plate with  the help of a sterile cotton bud  and 10-
20 μL of phage filtrate was spotted on bacterial lawn and plate was incubated at 37 °C 
for overnight.  After getting checked the supernatant by spot test, serial dilution was 
performed i.e. 10
–1
 to 10
–10
 in phage buffer {Tris HCl (1 M, pH 7.5), NaCl (5.8 g), 
MgSO4.7H2O (2.0 g) and gelatin (5.0 mL/L) in distilled water. The phage stocks was 
stored and diluted by phage buffers. Plaque assay of phages was performed by making 
a series of dilution ranging from 10
1
 to 10
10.  Approximately, 100 μL of each dilution 
was added to a sterile tube followed by 100 μL of the respective bacterial culture.  All 
the tubes were mixed gently and incubated at room temperature for 2-5 min in order 
to give time for phage to bind/adsorbed to bacteria.  Then 2 – 3 mL of top agar (LB 
media having 7 % agar) was poured in each tube. Tubes were mixed for a while and 
immediately poured into their appropriate nutrient agar plates. The plates were 
solidified and later on incubated for overnight at 37 °C. For phage purification, using 
a sterile tip, isolated plaques were picked. 5 – 10 mL log phase bacterial cultures was 
used for incubation of each plaque (log phase) at 37 °C with  continuous shaking at 
120 rpm for 6 h. Soft agar overlays were used for the preparation of phage stocks. A 
phage buffer of about 7 mL was added to a confluent phage lysed petriplate and the 
plate was incubated for 4 h at 37 °C along with constant shaking at 60 rpm. The phage 
filtrate was centrifuged at 14,000 rpm for 10 – 15 min to remove all the cells and 
debris. The supernatant was filtered through 0.45 μm filters and stored at 4 °C. 
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discarded and the pellet re-suspension was performed in 25 µL of 10% phosphate 
buffer saline (PBS). Sample buffer (25 µL) (1M Tris (pH 6.8) 1 mL, 1M DTT 2mL, 
SDS 0.4 g, Bromophenol blue 0.02 g, 100  % glycerol 2 mL, final volume adjusted to 
20 mL) and syringing was done with 5 cc syringe. After syringing, sample was 
denatured at pH 8.3. The gel was run at 120 V and proteins bands were visualized by 
Commassie staining. 
3.7.7.1.2 Gels Preparation 
The protein expression analyses were performed by SDS PAGE (12 %) as 
described by Laemmli (1970). 12 % resolving gel was prepared by 3.4 mL distilled 
water and 4 mL of 30 % degassed Acrylamide/BIS (Acrylamide was 29.2 g and 
0.8gm N’N’-bis-methylene acrylamide dissolved in 100 mL distilled water). 2.5 mL 
of 1.5 M Tris-HCL gel buffer (18.15 g Tris base dissolved in final 100 mL distilled 
water with pH 8.8), 100 µL  of 10 % SDS w/v and 150 µL of 10 % Ammonium per 
sulphate (APS). 8 µL of  N,N,N’,N’,tetraethylmethylendiamin(TEMED) (Research 
Organics,Cat#3009T) was mixed to it and poured in between the gel plates leaving 
some top area for resolving gel. A layer of distilled water was poured over the gel to 
prevent oxidation. Gel was left for 20 – 30 min for polymerization. The water was 
removed carefully with 5cc syringe and 6 % stacking gel was poured which was 
prepared by mixing 5.4 mL distilled water, 2 mL of 30 % degassed Acrylamide/BIS, 
2.5 mL of 0.5 M Tris-HCL gel buffer (6 g Tris base dissolved in final 100 mL 
distilled water with pH of 6.8), 100 µL 10 % SDS w/v, 150 µL 10 % APS and 8 µL 
TEMED. Comb (BIO-RAD) was placed in the stacking gel immediately after pouring 
and leaves it until it polymerizes. After polymerization, the gel plates were fixed in 
electrophoresis apparatus in placed in the gel tank (BIO-RAD). Tank was filled with 
Chapter 3                                                                                         Materials & Methods                        
  62 
 
gel running buffer (1X Tris-Glycine) up to the marked area for 2 gels. Sample (15 µL) 
was loaded in the well  and run the gel at 40 V till it entered into the resolving gel, 
increased the voltage to 120 V using BIO-RAD power supply, 5 µL of  broad range 
protein molecular weight markers (Precision Plus Protein™ , Bio-Red ) was run along 
with the sample in a separated well to compare the proteins sizes. Gel was run at a 
constant voltage supply 120 volts. 
3.7.7.1.3 Commassie staining and destining 
  The gel was stained in Commassie brilliant blue R-250 solution (50 mg dye 
in methanol: acetic acid: H2O at the ratio of 45:9:45 respectively) and destined with a 
mixture of methanol (5 %) and acetic acid (7 %) in water. Gel was stored in distaining 
solution and photographed. 
3.7.8 Phage Genome Isolation 
Genomic DNA of phage was extracted by kit (QIAGEN®, Cat No 12523) as 
prescribed by the manufacturer. A 50 ml of bacterial culture was established and 
incubate with a phage filtrate for 4 h at 37 °C. After incubation bacterial phage 
mixture was treated with chloroform (2 % v/v) and further incubated for 30 min at 37 
°C to increase lysis effectiveness. Then centrifugation of the mixture was carried out 
for 20 – 30 min at 15,000 rpm to discard bacterial debris. The supernatant containing 
phages was transferred into a new sterilized 50 mL falcon tube.  About 100 µLof 
buffer L1 (RNase A + DNase I) was added to 50 mL supernatant and followed by 
incubation for 30-40 min  at 37 °C to degrade bacterial RNA and DNA. Buffer L2 (10 
mL ice cold) was added (10 mL) and mix gently for proper mixing. Then the mixture 
was kept on ice for 60 min followed by centrifugation at 15,000 rpm for 10-15 min 
and the supernatant was discarded. After centrifugation and removal of the 
supernatant, the tube was placed upside down for 1–2 min to allow the residual liquid 
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to drain out. Re-suspension of the pellet in 3 mL of buffer L3 was done by pipetting 
up and down for several times to ensure complete re suspension of pellet. Buffer L4 
(about 3 mL) was added and mixed gently followed by incubation  at 70 °C for 20–30 
min and then cool on ice. After incubation, buffer L5 (about 3 ml) was added and 
thoroughly mixed by gently inverting the tube for 4–6 times followed by 
centrifugation for 30 min at 4 °C and 15,000 rpm. Supernatant was transferred 
promptly to a fresh tube followed by centrifugation again at 4 °C for 20 min at 15,000 
rpm to have a clean and clear phage filtrate (particle-free cleared lysate) to completely 
avoid applying particulate material to the column which cause blocking of column.  . 
Approximately 10 mL of buffer (QC) was used to wash QIAGEN-tip 100 and allowed 
to flow downwardly through the column by gravity. In a clean collection tube the 
DNA was eluted by passing about 1.5 mL buffer (QF) through the column.  
Precipitation of eluted DNA was performed by adding 3.5 mL iso-propanol followed 
by centrifugation at 14,000 rpm for 30 min at 4 °C. The supernatant was carefully 
decanted to avoid loss of DNA. DNA pellet was washed with 2 mL ethanol (70 %) 
and centrifuged at 15,000 rpm for 10-20 min. The supernatant was discarded and the 
pellet was air-dried for 10 –15 min. The pellet was re-dissolved in about 100-200 µL 
of TE buffer (pH 8.5). The quality of DNA was analyzed by nanodrop machine and 
agarose (0.7 %) gel electrophoresis.  
3.7.9 Restriction Enzyme Digestion 
Phages DNA were digested by restriction enzyme EcoR1 (New England 
Biolab, Canada) using standard methods (Sambrook et al., 1989). Reaction mixture 
(40 µL) was consisted of 20 µL Phage, 2 µL EcoR1, 4 µL buffer and 14 µL nuclease 
free water. The reaction mixture (40 µ l) was kept at 37 °C
 
in the incubator for 16 
hours. The reaction mixture was run on 1 % (w/v) agarose gel using TBE buffer. 40 µ 
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L of  the reaction mixture with 10 µL of the 6X loading buffer (Fermentas) was mixed 
and loaded on 1 %  agarose gel to run in 1X TBE. DNA molecular weight marker was 
also used as a reference. DNA was run at 50 mA current. The gel was visualized 
under the geldoc system. 
3.8 TESTING FITRATES OF DIFFERENT PHAGES AGAINST DIFFERENT 
BACTERIAL SPECIES 
The activity of different bacteriophages named  MJ1, AZ1, Z, MJ2 , WZ1, 
KH-49 ZA1, STH1, WN1 and  IQH1 isolated in Viral Lab 1 ASAB, NUST, 
Islamabad were tested against five different bacterial species i.e. Escherichia coli, P. 
aerugonisa, E. cloacae, K. pneumoniae and S. dysentery. The cross sensitivity of all 
the five bacterial species was determined by spot test in accordance in accordance 
with  Zimmer et al. (2002). To confirm the cross sensitivity of bacterial species, soft 
agar overlay method was used (Sillankorva et al., 2008).  The plates were observed 
for any plaque formation against an uninfected negative control after overnight 
incubation at 37 °C. 
3.9 SUSCEPTIBILITY OF PLANKTONIC CULTURES TO 
PHAGES 
Susceptibility of each bacterial strain was established in accordance with the 
protocol of Cerca et al. (2007). Cell suspension of each bacterial strain (susceptible to 
phage) was adjusted to ≤ 2× 108 cells/mL in normal saline (0.9 % NaCl) and added to 
20 ml of tryptic soy broth (TSB). The mixture was incubated at 37 °C with continuous 
shaking at 120 rpm, until a suitable bacterial cell density (≥ 2×108 cells/mL) was 
attained. The phage suspension was analyzed in bacterial culture at different 
multiplicities of infection (MOIs) i.e. 0, 0.1, 0.5, 1 and 5 for 5 h. Samples were taken 
out at different time interval followed by determination of OD at 600 nm. Each 
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sample was serially diluted and spread on TSA plates in triplicate followed by 
incubation overnight at 37 °C. Phage titer was also determined during bacterial 
growth by taking sample at each hour followed by serial dilution method. The 
experiment was repeated three times.  
3.10 SUSCEPTIBILITY OF BIOFILMS TO PHAGES 
Biofilm of each susceptible bacterial strain was developed according to Cerca 
et al. (2005a) with minor modifications. Each bacterial culture (10 µL, ≥108 CFU) 
grown overnight was 100 times diluted in TSB. Cell suspensions (100 µL, ≥ 2× 108 
cells) prepared in normal saline (0.9 % NaCl) solution were added to 96-wells plates 
containing tryptic soy broth with 1% glucose (TSBG). Biofilms were prepared by 
continuous shaking at 120 rpm and 37 °C for 24 h and 48 h. Planktonic cells were 
removed by washing the biofilms twice in normal saline. A suitable titer of each 
phage (diluted in normal saline) was introduced to one half of the wells while the 
other half was used as a control (negative). These micro plates were kept at 130 rpm 
and 37 °C. The plates were washed in normal saline (twice), dried, inverted and 
crystal violet stained (1 %) for approximately 20 min. After staining, the plates were 
washed thrice with distilled water and invertedly dried. Approximately an aliquot of 
200 µL of normal saline solution was added to each well and the total biomass of the 
biofilms was described in accordance with Cerca et al. (2005b). The OD was 
measured by an ELISA plate reader at 570 nm and the experiment was repeated 
thrice. 
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3.11 VULNERABILITY OF BIOFILM-GROWN CELLS VERSUS 
PLANKTONIC CULTURES TO PHAGES 
Selection of each bacterial strain was done to test the susceptibility of biofilm 
grown cells to their respective phage. Bacteria biofilm was formed on plate surfaces 
and then scraped to mix in normal saline solution in accordance with the protocol of 
Cerca et al. (2005a) with minor modifications. Suspended biofilm was vortexed for 20 
sec and for disintegration of biofilm sonication was done for 20 sec during 10 sec at 
10 W. For stationary growth phase of bacteria, bacterial cultures were established in 
TSB for 24 h. Centrifugation of the suspension was done at 14,000 rpm for 6 min 
followed by re-suspension of the bacterial pellet in normal saline. The suspension was 
vortexed for 20 sec and sonicated at 10 W for 6 sec. Both suspensions were diluted in 
a poor nutrient medium (10 % TSB diluted in 0.9 % NaCl) to get an OD of 0.4 at 600 
nm. A serial dilution method was used to calculate CFU in accordance with 
Sillankorva et al. (2008). In each suspension, phage at an appropriate MOI of 1.0 was 
added.  OD reductions for both types of cell suspensions were calculated for 5 h by 
comparing with a control without phage. Experiment was repeated thrice. 
3.12 BIOFILM STUDY USING STAINLESS STEEL PLATES 
3.12.1 Development of Biofilm on Stainless Steel Plates  
 In this study stainless steel (SS) plates (1 cm x 1 cm) were used for 
development of biofilms for different time periods in a 6 well plates.  Two major 
conditions were considered for biofilm formation i.e. static and dynamic with the 
removal of media in both cases after each 12 hours and also another dynamic 
condition without removal of media after 12 hour (Table 3.1). SS plates in 6-well 
plates were incubated at 37 °C. Biofilms formed at different time intervals were 
detected.  Sterilization of SS plates was performed for biofilm study.  SS plates were 
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washed with 100 % acetone. The plates were immersed in alkaline detergent (1 % 
NaOH (w/v), pH 13.2) for washing for 1 hour. The SS plates were rinsed in distilled 
water (sterilized) and dried cleaned with alcohol (70 % (v/v)). The plates were again 
washed with distilled water (sterilized) and dried for 2 h at 60 ºC.  Finally the plates 
were sterilized by autoclaving at 121 ºC for 15 min. 
Table 3.1: Conditions for Biofilm Development. 
S:# Condition Time of biofilm development 
(incubation at 37 °C) 
1 Static condition 
(Static incubator) 
Removal of media 
24 hours 72 hours 120 hours 
2 Dynamic condition 
(shaking water bath 
incubator) 
Removal of media 
24 hours 
 
72 hours 120 hours 
3 Dynamic condition 
(shaking water bath 
incubator) 
Without removal of media 
24 hours 72 hours 120 hours 
 
3.12.2 Development of Biofilm and its CFU Determination 
Biofilms  were formed for different time  period on SS plates as described by 
Cerca et al. (2005b) with minor modifications. Briefly, the SS plates were placed in 
six well plates and 50 µL bacterial culture (OD = 1 at 600 nm)   were deposited on SS 
plates and 6 mL of TSB was added to well in such way not to disturbed the bacterial 
culture on plate surface. The six well plates having SS plates were incubated at 
different conditions (static and dynamic with or with out media removal) for 24 h, 48 
h and 72 h at 37 °C. Bacterial cells count on SS plates (1cm x 1cm) for biofilms 
formed after different time intervals were determined in accordance with the protocol 
of Sillankorva et al. (2008). At same time a negative control (biofilms immersed 
overnight in SM and TSB buffer) was also investigated. The SS plates with biofilms 
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were washed carefully by immersion in a freshly prepared PBS (1X). These washed 
SS plates were transferred into a tube containing 3 ml of normal saline and vortexed 
vigoursly with high speed. Afterwards, serial dilutions were prepared and CFU was 
calculated by spreading various dilutions on TS agar plates. 
3.12.3 Application of Bacteriophage 
 Bacterial bioflms formed under different conditions were treated with phage 
stock suspensions. Biofilms formed for 24 h, 48 h and 72 h, were treated with phage 
suspensions for four hour.  After phage treatment, the SS plates (biofilms) were 
immersed carefully  fresh PBS (1X)  ant then transferred to new fresh well containing 
3 mL of TSB and 3 ml of phage suspensions. These microplates containing SS plates 
were placed at 37 °C for 4 hour. At the same time negative control experiments were 
done. Effect of phage suspension on bacterial biofilms prior and post phage treatment 
was analysed (Sillankorva et al., 2008). Phage suspension treated SS plates were 
washed in PBS (1X) solution.  After phage treatment of SS plate were rained carefully 
in PBS (1X) and consequently transferred to tube containing 3 ml normal saline. 
These SS plates were vortexed vigorously in such a way to remove all the phages 
adhering to SS plate surfaces. After this serially dilutions were formed in SM buffer 
and soft ager overlay assay was performed for CFU calculations in accordance with 
Cerca et al. (2007). 
3.12.4 Biofilm Dry Weight Determinations 
           Biofilms dry weights were determined according to the protocol of Henriques 
et al. (2005) with slight modifications. The biofilms samples (SS plates) formed under 
different time spins and static/dynamic conditions were removed for the wells of 
microplates with the help of a sterile forceps and carefully rained in PBS (1X) and 
then dried for 24 hours at 100 °C and weighed. After this the SS plates were washed 
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very carefully to remove the whole biofilms completely. After second time washing 
the SS plates were dried by the same way as described above. Dry weights of SS 
plates were determined and considered these plates as an empty control. The percent 
biofilms reduction was performed by using this formula  
               
                        
            
     
3.12.5 Biofilm Fixation for Scanning Electron Microscopy  
Biofilm formed on SS slides were fixed by in accordance with Sillankorva et 
al. (2008) with slight modifications. SS plates were removed from media with the 
help of forceps and carefully washed by dipping three times in PBS (1X) solution. 
After PBS washing the SS plates were placed in gluteraldehyde (2.5 %) at 4 °C and 
fixed for one hour.  After fixation the SS plates were subjected to drying procedure by 
using ethanol series. Biofilm samples were dehydrated with an ethanol series ranging 
from 30 % to 100 %. Each step of ethanol treatment was ranging from 5–10 min. 
After drying the biofilm SS plates after drying were further processed for SEM 
analysis. Biofilm formed on SS plates were mounted on carbon adhesive tabs, on 
aluminium specimen mounts. SS plates were leaved for conduction with Au/Pd 
(Denton Desk II sputter coater). For biofilm detection, both treated and control SS 
plates were examined under scanning electron microscope (Hitachi S-4000 FE-SEM, 
High Technologies America, USA) and scanning electron micrographs of high 
magnifications were obtained through software (PCI Quartz) at Electron Microscopy 
and Bio-Imaging lab (EMBL), Interdisciplinary Center for Biotechnology Research 
(ICBR), University of Florida (UF) USA. 
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Chapter 4 
RESULTS 
4.1 BACTERIAL IDENTIFICATION 
Bacterial strains such as E. coli, P. aeruginosa and K. pneumoniae obtained 
from local hospitals were identified by a biochemical test (Gram staining). Gram 
staining results revealed that these were Gram-negative bacteria (Figure 4.1). 
Identification of these bacterial strains was further confirmed by ribotyping of the 16S 
rRNA gene. For each strain a 470 bp amplicon was amplified and subjected to DNA 
sequencing from both orientations (Figure 4.2). The resulted sequences were 
deposited to a database and GenBank Accession ID: KF385446, KF385446, 
KJ438818 were obtained for E. coli, P. aeruginosa and K. pneumoniae, respectively.  
Sequences were aligned to search for the most similar sequences. In the BLAST 
analysis showed a high nucleotide sequence identity of 99 % to E. coli, 100 % to P. 
aeruginosa and 99 % to K. pneumoniae, respectively. The other two bacteria used in 
this study i.e. E. cloacae and S. dysenteriae were previously confirmed with Gen 
Bank Accession ID: JQ863238 and JX560100, respectively. 
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Figure 4.1: Gram staining of bacterial strains. (A) showing Gram staining result 
for E. coli, (B) for P. aeruginosa and (C) for K. pneumoniae. 
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Figure 4.2: Identification of bacterial strains by ribotyping. Amplification of 16S 
rRNA gene sequence of E. coli, P. aeruginosa, K. pneumoniae, E. cloacae and S. 
dysenteriae by polymerase chain reaction (PCR). Lane 2, 3, 4, 5 and 6 show bands of 
amplified DNAs (approximately 470 bp) while Lane 1 shows a DNA Ladder 
(GeneRuler 1 kb Plus, Thermo Scientific) 
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4.2 ISOLATION AND CHARACTERIZATION OF PHAGES 
4.2.1 Isolation of phages 
By the soft agar overlay method using E. coli, P. aeruginosa, K. pneumoniae, 
E. cloacae and S. dysenteriae as host organisms, phages were isolated from waste 
water samples. All the phages gave a clear zone on spot test (Figure 4.3). The isolated 
phages were designated MJ1, AZ1, Z, MJ2 and WZ1.These phages produced clear 
plaques on the lawn of the hosts, indicating that these were virulent phages. Phage 
MJ1, AZ1, Z, MJ2 and WZ1 were having plaques size of 0.8 mm, 0.7 mm, 2.6 mm, 2 
mm and 1.4 mm in diameter, respectively. Each phage showed plaques with well-
defined boundaries (Figure 4.4). 
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Figure 4.3: Phage spot Assay. Soft agar overlay plates showing spot test. Plate A1, A2, A3, 
A4 and A5 showing spot assay of phage MJ1 against E. coli, AZ1 against P. aeruginosa, MJ2 
against  E. cloacae, Z against K. pneumoniae and WZ1 against S. dysenteriae, respectively. 
All the phages formed clear spots on their host bacterial lawns.  
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Figure 4.4: Soft agar overlay Assay. Soft agar overlay plate B1, B2, B3, B4 and B5 showing 
plaque assays of phage MJ1, AZ1, MJ2, Z and WZ1, respectively. Phage MJ1, AZ1, MJ2, Z 
and WZ1 having  an average plaques size of  0.8 mm, 0.7 mm, 2.6 mm, 2 mm and 1.4 
mm in diameters, respectively. All phages showed clear plaques of with well-defined 
boundaries.  
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4.2.2 Host Range Determination 
 About 88 bacterial strains were tested to determine host range of each phage 
by using spot test method. Phage MJ1 showed activity against E. coli, E. coli F, 
Escherichia coli LF-1968, Achromobacter xylosoxidans and K. pneumoniae on spot 
test (Table 4.1) but only produced plaques against E. coli, E. coli F, Escherichia coli 
LF-1968 and Achromobacter xylosoxidans on ager overlay assay. 
  Phage AZ1 showed activity against P. aeruginosa, P. aeruginosa-2949, P. 
aeruginosa-37, E. coli CR-061 and Achromobacter xylosoxidans on spot test (Table 
4.1) but only produced plaques against P. aeruginosa, P. aeruginosa-2949, P. 
aeruginosa-37 and Achromobacter xylosoxidans on ager overlay assay. 
            Phage MJ2 showed activity against E. cloacae, E. cloaca-101, E. cloacae-105, 
Achromobacter xylosoxidans, K. pneumoniae-3 and Pseudomonas aeruginosa on spot 
test (Table 4.1) but produced plaques only against E. cloacae, E. cloaca-101, E. 
cloacae-105and Achromobacter xylosoxidans on ager overlay assay.  
 Similarly, phage Z showed activity against K. pneumoniae, K. pneumoniae-
3206 K. pneumoniae-3, Achromobacter xylosoxidans and P. aeruginosa on spot test 
(Table 4.1) but only produced plaques against K. pneumoniae, K. pneumoniae-3206 
K. pneumoniae-3 and Achromobacter xylosoxidans on ager overlay assay. 
 While phage WZ1 showed activity against S. dysenteriaea, S. dysenteriae-
209, S. dysenteriae-208, Achromobacter xylosoxidans and K. pneumoniae-3206 on 
spot test (Table 4.1) but only produced plaques against S. dysenteriaea, S. 
dysenteriae-209, S. dysenteriae-208 and Achromobacter xylosoxidans. Among these 
all bacterial strains, Achromobacter xylosoxidans was the most common susceptible 
strain which was lysed by the all phages. 
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4.2.3 Thermal Stability 
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Figure 4.5: Thermal stability test. Stability of phage MJ1, AZ1 and MJ2 treated with 
different temperature for 60 min. Here (A), (B) and (C), are showing thermal stability of 
MJ1, AZ1 and MJ2, respectively. Values are the means of 3 determinations with ± 
standard deviations. 
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Figure 4.6: Thermal stability test. Stability of phage Z and WZ1 treated with different 
temperature for 60 min. Here (D) and (E) showing thermal stability of phage Z and WZ1, 
respectively. Values are the means of 3 determinations with ± standard deviations. 
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4.2.4 pH Stability 
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Figure 4.7: pH stability test. Stability of phage MJ1, AZ1 and MJ2 treated with different 
pH overnight at 37 °C for 16 hours. Here, (A), (B) and (C) showing pH stability of MJ1, 
AZ1 and MJ2, respectively. Values are the means of 3 determinations with ± standard 
deviations. 
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Figure 4.8: pH stability test. Stability of phage Z and WZ1 treated with different pH 
values for 16 hours. Here, (D) and (E) showing pH stability of phage Z and WZ1, 
respectively. Values are the means of 3 determinations with ± standard deviations. 
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4.2.5 Calcium and Magnesium Ions Effect on the Adsorption Rate of Phages 
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Figure 4.9: Adsorption rate test. At different time intervals, samples were taken from the 
supernatants to measure free phage particles. Divalent metal ions effect on adsorption rates 
were analyzed by adding 10 mM CaCl2 or MgCl2 to the mixture of phage MJ1and E. coli 
cells (A), MJ2 and E. cloacae cells (B) and Z and K. pneumoniae cells (C), respectively. 
Significant reduction in free phages in suspension as compared with control (Red and green 
band; paired samples t-test, p < 0.05). Values are the means of 3 determinations with ± SD. 
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Figure 4.10: Adsorption rate test. At different time intervals, samples were taken from the 
supernatants to measure free phage particles. Divalent metal ions effect on adsorption rates 
were analyzed by adding 10 mM CaCl2 to the mixture of phage AZ1 and P. aeruginosa cells 
(D) and WZ1 and S. dysenteriae cells (E), respectively. Significant reduction in free phages in 
suspension as compared with control (Red band; paired samples t-test, p < 0.05). Values are 
the means of 3 determinations with ± SD. 
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4.2.6 Latent Time Period and Burst Size 
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Figure 4.11: One step growth experiment. Latent time and burst size of phage MJ1 (A), 
phage AZ1 (B) and phage MJ2 (C) were inferred from the curve with a triphasic pattern. 
Values are the means of 3 determinations with ± SD. 
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Figure 4.12: One step growth experiment. Latent time and burst size of phage Z (B) and 
phage WZ1 (E) were inferred from the curve with a triphasic pattern. Values are the means 
of 3 determinations with ± standard deviations. 
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4.2.7 Morphology of Phages 
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Figure 4.13: Transmission electron microscopy of phage. Transmission electron 
micrographs of the purified phage MJ1. Scale bars, 200 nm. Three representative images  
are shown such as A1, A2 and A3, respectively. 
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Figure 4.14: Transmission electron microscopy of phage. Transmission electron 
micrographs of the purified phage AZ1. Scale bars, 200 nm. Three representative images  
are shown such as B1, B2 and B3, respectively. 
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Figure 4.15: Transmission electron microscopy of phages. Transmission electron 
micrographs of the purified phage. Scale bars, 200 nm. Three representative images  are 
shown such as and C1, C2, C3, respectively. 
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4.16: Transmission electron microscopy of phages. Transmission electron micrographs of 
the purified phage Z. Scale bars, 200 nm.  Three representative images are shown such as 
D1, D2 and D3, respectively. 
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Figure 4.17: Transmission electron microscopy of phages. Transmission electron 
micrographs of the purified phage WZ1. Scale bars, 200 nm.  Three representative images  
are shown such as and E1, E2, and E3, respectively. 
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4.2.8 Phage Structural Proteins 
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Figure 4.18: Phage proteins analysis. SDS-PAGE analysis of structural proteins of phage 
MJ1 (A), MJ2 (B), AZ1 (C), WZ1 (D)  and  Z (E). In each gel Lane 1 represents broad range 
protein molecular weight markers (Precision Plus Protein™, Bio-Red); while Lane 2, phage 
structural proteins. 
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4.2.9 Genome Isolation of Bacteriophages 
 Phages were amplified and their nucleic acids were isolated.  Nucleic acids of 
five phages named MJ1, AZ1, MJ2, Z and WZ1 were isolated by Lambda Maxi Kit 
(Qiagen) and were detected by agarose gel. Phages MJ1, AZ1, MJ2, Z and WZ1 have 
genome sizes of approximately 32 kb, 50 kb, 40 kb 36 kb, and 38 kb, respectively 
{Figure 4.19 (A, B, C, D and E)}. 
4.2.10 Restriction of Phage Genome with EcoR1 Enzyme  
Upon  EcoR1 restriction, nucleic acid of phage MJ1, AZ1, MJ2, Z and WZ1 gave 2, 9, 
2, 2 and 3 bands, respectively (Figure 4.20 {A, B, C, D and E}). 
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Figure 4.19: Isolation of phage genome (0.7 % agarose). A, B, C, D and E showing 
genome of phages MJ1, MJ2, AZ1, Z and WZ1, respectively. Lane 1 in each figure (gel) 
shows GeneRuler High Range DNA Ladder and Lane 2, shows band of phage genomic 
DNA. 
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Figure 4.20: Restriction analysis of phage genome (0.7 % agarose). Here, A, B, C, D 
and E showing EcoR1 restriction analysis of genome of phage MJ1, AZ1, Z, MJ2 and WZ1, 
respectively. Lane 1 in each gel shows GeneRuler High Range DNA Ladder and Lane 2, 
shows restriction of phage genomic DNA with EcoR1.  
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4.4 DETECTION OF BACTERIAL BIOBILM 
Thirty bacterial strains (Table 4.3) were tested for their biofilm formation 
ability. These were including bacterial strains from five different bacterial species i.e. 
E. coli, P. aeruginosa, K. pneumoniae, E. cloacae and S. dysenteriae. For detection 
and quantification of biofilm 96-well plate assay was performed. Optical density was 
measured at 600 nm.  Among these thirty different bacterial strains, one bacterium 
from each group out of five with significant biofilm formation ability was selected as 
host organism for phage isolation and other biofilm experiments. The bacterial strains 
with good biofilm ability were E. coli, P. aeruginosa, K. pneumoniae, E. cloacae and 
S. dysenteriae. Maximum biofilm formation was shown by P. aeruginosa followed by 
K. pneumoniae, S. dysenteriae, E. coli and E. cloacae, respectively (Figure 4.21).  
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Figure 4.21: Detection of biofilm formation. Biofilm formation ability of different bacterial strains for 48 hours. Biofilms formed by different 
bacterial species I.e. E. coli, P. aeruginosa, Enterobacter cloacae, K. pneumoniae and S. dysenteriae with a negative control. 
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Figure 4.22: Bacterial growth reduction curve. Bacterial growth reduction curves of 
exponential growth phase planktonic E. coli (A) by phage MJ1, E. cloacae (B) by phage MJ2 
at different multiplicity of infection (MOI): 0, 0.1, 0.5, 1 and 5.  
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Figure 4.23: Bacterial growth reduction curve. Bacterial growth reduction curves of 
exponential growth phase planktonic K. pneumoniae (C) by phage Z and (D) S. dysenteriae 
by phage WZ1, at different multiplicity of infection (MOI): 0, 0.1, 0.5, 1 and 5.  
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Figure 4.26: Bacterial growth reduction curve. Reduction curves of E. coli (A) and E. 
cloacae (B) in different growth stages: stationary phase bacteria (control and with phage), 
or biofilm grown bacteria (control and with phage). 
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Figure 4.27: Bacterial growth reduction curve. Reduction curves of K. pneumoniae (C) 
and S. dysenteriae (D), in different growth stages: stationary phase bacteria (control and 
with phage), or biofilm grown bacteria (control and with phage). Values are the means of 3 
determinations. 
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Figure 4.28: Bacterial growth reduction. Reduction curves of exponential growth phase 
planktonic P. aeruginosa by phage AZ1, KH-49, MJ1 and phage cocktail at approximately 
MOI of 1.0. Values are the means of 3 determinations. 
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4.8 Bacterial biofilms formed under different conditions 
 
Figure 4.30 (A) showing E. cloacae biofilm under static conditions with 
renewal of media for 24 h, 72 h and 120 h formed were phage treated for 4 hour 
showing biomass reduction of 3-log, 3.2-log and 4-log, respectively (A). Figure 4.30 
(B) biofilm under dynamic condition with renewal of media under static conditions 
for 24 h, 72 h and 120 h formed were phage treated for 4 hour showing biomass 
reduction of 2.5-log, 3-log and 3.5-log, respectively. Figure 4.30 (C) biofilm under 
static conditions for 24 h, 72 h and 120 h were formed were phage treated for 4 hour 
showing biomass reduction of 2.8-log and 3-log, respectively. 
 Figure 4.31, showing representative scanning electron micrographs of E. 
cloacae biofilms formed under static condition with renewal of media and treated for 
4 hour phage degradation through application of phage. Scanning electron 
micrographs are exhibiting development of biofilm for 24 h, 72 h and 120 h under 
static conditions and its degradation through application of phage.   
Figure 4.32 (A), showing K. pneumoniae biofilm under static conditions with 
renewal of media for 24 h, 72 h and 120 h formed were phage treated for 4 hour 
showing biomass reduction of 2.3-log, 2.2-log and 3.2-log, respectively. Figure 4.32 
(B) biofilm under dynamic condition with renewal of media under static conditions 
for 24 h, 72 h and 120 h formed were phage treated for 4 hour showing biomass 
reduction of 2.2-log, 2.3-log and 3.2-log, respectively. Figure 4.32 (C), biofilm under 
static conditions for 24 h, 72 h and 120 h formed were phage treated for 4 hour 
showing biomass reduction of 2.1-log and 3-log, respectively. 
Figure 4.33, showing representative scanning electron micrographs of K. 
pneumoniae biofilms formed under static condition with renewal of media and treated 
for 4 hour phage degradation through application of phage. Scanning electron 
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micrographs are exhibiting development of biofilm for 24 h, 72 h and 120 h under 
static conditions and its degradation through application of phage {Figure 4.34 (C1, 
C2, C3 and T1, T2, T)}. 
The action of phage AZ1, MJ1, KH-49 versus phage cocktail was determined 
on P. aeruginosa 48 hour old biofilm formed on SS plates.  The already formed 
biofilms were challenged with phage AZ1, KH-49, MJ1 and a phage cocktail for 6 
hours. The biomass reduction of the biofilm was determined in the form of colony-
forming unit (CFU).We observed evident difference in bacterial biofilm biomass 
among treated samples  and the control (untreated) (Figure 4.34). AZ1, KH-49, MJ1 
and phage cocktail showed about 3-log, 2.3-log, 1-log and 6-log reductions, 
respectively. Hence, the phage cocktail showed a remarkable effect, causing an 
obvious eradication (about 6-log) of the biofilm (statistically determined by paired 
samples t-test (P <0.05) when compared with other phages (i.e. AZ1, KH-49, MJ) and 
control.  Figure 4.35,  showing scanning electron microscopy of biofilm (48 hours), 
(A) and (B) showing the 48 hour (two-day-old) biofilms of P. aeruginosa (biofilm 
with out phage). Similarly, (C), (D), (E) and (F) showing the effect of phage AZ1, 
KH-49, MJ1 and phage cocktail on (two-day-old) biofilms, respectively.   
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Figure 4.34: Scanning electron microscopy of P. aeruginosa biofilms (48 hours). (A) 
and (B) showing the 48 hour (two-day-old) biofilms of P. aeruginosa (biofilm with out 
phage). Similarly, (C), (D), (E) and (F) showing the effect of phage AZ1, KH-49, MJ1 and 
phage cocktail on (two-day-old) biofilms, respectively.   
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4.9 Biofilm Dry Weigh Determination  
Dry weigh of biofilms of E. cloacae developed during static condition with 
renewal of medium were determined. Table 4.4 shows the dry weight of E cloacae 
biofilms on the SS plates before and post four hours treatment with phage and 
decrease in biomass was observed after applying phage to different time interval of  
biofilms.  
For SR biofilm, developed for 24 h, 72 h and 120 h and four hour phage 
treatment, reductions of 55 %, 53.60 % and 49 % were observed, respectively.  
Similarly for DR biofilm, developed for 24 h, 72 h and 120 h and four hour phage 
treatment, a reduction of 53 %, 50 % and 47 % were observed, respectively. For DNR 
biofilm, developed for 24 h and 72 h and four hour phage treatment, reductions of 51 
% and 49 % were observed, respectively 
Dry weigh of biofilms of K. pneumoniae developed during static condition 
with renewal of medium were determined. Table 4.5 shows the dry weight of K. 
pneumoniae biofilms on the SS plates before and post four hours treatment with 
phage and decrease in biomass was after applying phage to different time interval of 
bioflms. 
For SR biofilm, developed for 24 h, 72 h and 120 h and four hour phage 
treatment, reductions of 46 %, 43 % and 36 % were observed, respectively.  Similarly 
for DR biofilm, developed for 24 h, 72 h and 120 h and four hour phage treatment, a 
reductions of 45 %, 42 % and 32 % were observed, respectively. For DNR biofilm, 
developed for 24 h and 72 h and four hour phage treatment, reductions of 45 % and 39 
% were observed, respectively. 
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Table 4.5: E. cloacae biomass before and after four (4) hour of phage application 
to biofilm and percentage (%) removal of biomass. 
 
 
SR = Static with media renewal, DR = Dynamic with media renewal, 
DNR = Dynamic with non renewal of media and SD = Standard deviation 
 
 
 
 
 
Condition Bifilm Age 
(Hours) 
Biofilm Control     
(+/- SD) 
Biomass End 
(4 hour phage 
treatment)(+/- SD) 
Biomass 
Removal 
(%) 
 
SR 24 7.85 (1.20) 3.50 (1.25) 55  
SR 72 11.7 (2.35) 5.40 (1.00) 53.60  
SR 120 14.8 (3.16) 6.40 (1.35) 49  
 
DR 24 7.50 (1.00) 3.6 (0.6) 53  
DR 72 8.16 (1.12) 4.1 (1.2) 50  
DR 120 9.29 (2.11) 4.9 (0.46) 47.2  
 
DNR 24 7.20 (1.15) 3.40 (1.00) 51.00  
DNR 72 7.95 (2.2) 4.45 (0.98) 49  
Chapter 4                                                                                                                Results 
  130 
 
Table 4.6:  K. pneumoniae biomass before and after four (4) hour of phage 
application to biofilm and percentage (%) removal of biomass. 
 
 
SR = Static with media renewal, DR = Dynamic with media renewal, 
DNR = Dynamic with non renewal of media and SD = Standard deviation 
Condition Bifilm 
Age 
(Hours) 
Biofilm 
Control (± SD) 
Biomass End 
(4 hour Phage 
treatment)(± SD) 
Biomass 
Removal 
(%) 
 
 
SR 
 
24 
 
7.85 (1.20) 
 
4.20 (1.25) 
 
46 
 
SR 
 
72 
 
11.7 (2.35) 
 
6.70 (1.00) 
 
43 
 
SR 
 
120 
 
14.8 (3.16) 
 
9.40 (1.35) 
 
36 
 
 
DR 
 
24 
 
7.70 (1.00) 
 
3.6   (0.6) 
 
45 
 
DR 
 
72 
 
9.10 (1.12) 
 
 
5.2 (1.2) 
 
42 
 
DR 
 
 
120 
 
10.30 (2.11) 
 
7 (0.46) 
 
32 
 
 
DNR 
 
24 
 
7.30 (1.15) 
 
4.0 (1.00) 
 
45 
 
DNR 
 
72 
 
8.5 (2.2) 
 
5.2 (0.98) 
 
39 
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DISCUSSION 
Biofilms are aggregates of microorganisms adhering to biological or inert 
surfaces. These surfaces are then surrounded by an adhesive matrix of extracellular 
polymeric substance (EPS) that are secreted by the microorganisms within the biofilm 
(Rao et al., 2005; Harper et al., 2014). Donlan and Costerton (2002) reported that 
Leeuwenhoek was the first person to observe the bacterial biofilm of his own teeth 
(plaque) by using simple microscope. Heukelekian and Heller (1940) observed 
increased growth of microorganisms in a container by providing surfaces to which 
these microorganisms could adhere. Zobell (1943) noticed that in sea water higher 
numbers of bacterial cells were adhered to surfaces when compared to bacteria 
floating in the surrounding medium. 
According to Vasudevan (2014) the chemical composition of biofilms is very 
complex and comprised of various components such as microbial cells, extracellular 
polymeric matrices (EPS), proteins, lipids, DNA, RNA and enzymes. In addition to 
these components, water is the major part of biofilm which is responsible for the 
inflow of nutrients inside to the biofilm matrix. These different components determine 
the biofilm integrity and make it resistant against various environmental factors. 
According to Flemming et al. (2000) biofilm basically consists of two main 
components: microbial cells and extracellular polymeric substance (EPS). The biofilm 
organic matter is comprised of extracellular DNA, lipids, proteins and 
polysaccharides (Hall et al., 2004). The total organic matter of a biofilm is comprised 
of about 50 % to 90 % EPS (Flemming et al., 2000). EPS of biofilm containing a 
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large amount of water (hydrated) has a hydrophilic nature. However, generally 
biofilms are of both natures: hydrophilic and hydrophobic (Sutherland, 2001). 
Historically an assumption had been made by the community of medical 
sciences that free-floating (planktonic) bacteria growing in liquid or broth cultures are 
causative agents of clinically relevant infections. However, extensive research in 
biofilms for the past 2 decades has shown that chronic infections are frequently 
related to adhered life-mode of bacteria living in biofilms (James et al., 2008). 
Biofilms are involved in many serious infectious diseases (Choisy, 2010). Biofilm-
associated infections are usually chronic infections due to their persistent nature and 
slow development which is rarely resolved by the immune defense system (both 
innate and adaptive) and most often are poorly responding to antibiotic therapy 
(James et al., 2008). 
Bacterial biofilm is infectious in nature and can result in nosocomial infections 
(Donlan, 2009). Approximately more than 60 % of nosocomial infections are due to 
biofilms (Donlan and Costerton, 2002; Vinh and Embil, 2005). According to 
estimations of National Institutes of Health (NIH), in almost 80 % of all chronic 
infections, there is role of biofilms (Monroe, 2007), and among all microbial 
infections approximately 65 % are associated with biofilms (Potera, 1999). 
It has been revealed by the discovery of microscopic observations that most 
bacteria (99.9 %) are able to form biofilms on living and non-living surfaces 
(Costerton et al., 1978). For example, E. coli spp, Stereptococcus epidermidis, 
Salmonella spp, S. aureus, Pasteurella multocida and Streptococcus mutans, all are 
capable of producing biofilms (Miller and Bassler, 2001; Parsek and Singh, 2003; Fux 
et al., 2005; Ma et al., 2009). 
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The emergence of resistance to available antibiotics strengthens the need to 
explore more effective strategies to control biofilm-associated infections (Lyczak et 
al., 2002). At the same time new strategies have been anticipated to disrupt biofilms, 
down-regulating the known virulence factors, regulating the genes engaged in 
pathogenesis and quorum sensing (Mah and O'Toole, 2001; Hentzer and Givskov, 
2003; Hentzer et al., 2003). 
The biofilm resistance to antibiotics is still not totally understood and 
antibiotic therapy failure to treat biofilm infections has strengthened the need to 
explore new strategies for removal of biofilms (Azeredo and Sutherland, 2008). 
Bacterial conventional antibiotic resistance in liquid culture or suspension is due to 
the presence of efflux pumps such as the multiple antibiotic resistance (MAR) loci, 
enzymes (modifying), target mutations and plasmids carrying resistance genes 
(Alekshun et al., 1999; Walsh et al., 2000), which may not be predominantly 
responsible for resistance in sessile bacteria (biofilm). This is supported by the fact 
that upon dispersion of biofilm, bacteria become susceptible to the conventional 
treatment, which suggests that the resistance is not necessarily due to genes (Anwar et 
al., 1989; Gilbert et al., 1997). Several authors have suggested three mechanisms 
(hypotheses) for bacterial resistance in biofilm. The first one features the incomplete 
or low penetration of antibiotics within the biofilm (Mah and O’Toole, 2001), 
whereas the second mechanism highlights the altered biofilm micro-environment 
which may be an obstacle to the activity of antibiotics. A third mechanism for the 
resistance of biofilms may be the differentiation of bacterial cells into a biofilm 
resistant phenotype (Goto et al., 1999; Brooun et al., 2000). The microbes which are 
 Chapter 5                                                                                                        Discussion                                                                                                                                                    
                                                                                                                                                                                            
                                                                 
 
  134 
 
growing as biofilm are extremely unresponsive to commonly used antibiotics and 
antibacterial drugs (Hall et al., 2004). 
The most frequent use of antimicrobials agents and other settings has also 
accelerated the evolution of resistant microbes (Archibald et al., 1997; Sieradzki et 
al., 2003). Bacteriophages are often regarded as substitution option of antibiotics for 
controlling bacterial contamination and infection (Nakai and Park, 2002). Many 
phages are capable of producing depolymerases to devastate bacterial biofilm. 
Researchers have advised phage therapy for controlling the emergence of 
antibiotic resistant bacteria instead of increasing antibiotic usage. Phage therapy is 
defined as treatment of bacterial infections  with phages (Nakai and Park, 2002). 
Phage therapy is the most potential approache to manage bacterial infections. Phage 
therapy is highly successful due to its high discriminatory nature. Generally each 
phage interrelates with a precise set of bacteria exhibiting particular binding sites. But 
his narrow host range is also a noteworthy confront for phage therapy (Smith and 
Huggins 1982; 1983; Smith et al. 1987). 
Phage therapy is used for controlling both plants and animals infectious 
diseases (Barrow et al., 1998). Phages therapy is used for those wound healing that 
are highly resistant to other microbial agents and also being used for treating different 
infectious diseases (Monk et al., 2010). 
It is presumed that approximately 10
31
 bacteriophages are present in the 
environment (Ashelford et al., 2000). Host range capability of these phages may also 
vary from narrow to broad. Therefore, due to the presence of such qualities, it often 
seems relatively easy to isolate phages against major bacterial pathogens, such as E. 
coli, P. aeruginosa, Campylobacter, Salmonella and S. aureus (Hyman and Abedon, 
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2010). Hence, it is crucial to isolate and characterize new phages especially against 
the in light of the observation that most of the disease-causing organisms live in the 
matrix-enclosed environments of the biofilms (Watnick and Kolter, 2000) that 
inherently show increased resistance toward all antibiotics (Gilbert et al., 1997). 
Since our study was focused on biofilm forming bacteria, we therefore 
determined the biofilm formation ability of approximately 30 bacterial strains was 
considered in this study (Figure 4.24). 
The most abundant organisms i.e. there exist 10
31 
phage particles on the planet 
Earth (Hendrix et al., 1999), it is easier to isolate phages against different antibiotic-
resistant bacteria than to develop new antibiotics. We isolated five (5) bacteriophages 
from sewage water samples. These phages were named: MJ1, AZ1, MJ2, Z and WZ1. 
Phage MJ1 targets E. coli, AZ1 targets P. aeruginosa, MJ2 targets E. cloacae, Z 
targets K. pneumoniae, and WZ1 targets S. dysenteriae, respectively (Figure 4.8).  
Phages are mostly isolated from the environments of their respective host 
bacteria (Nakai and Park, 2002). It is known that sewage generally contains a large 
diversity of microorganisms due to the contamination from fecal material and hospital 
drainage water (Piracha et al., 2014). 
All the newly isolated phages were lytic and had narrow host ranges. 
According to Hyman and Abedon (2010) the phages host range can vary from quite 
narrow (just a subset of strains within a single species) to quite broad (with host range 
spanning multiple bacterial genera). Phage MJ1 produced plaques having size from 
0.3 to 1.0 mm in diameter and infected only E. coli, E. coli LF-1969, E. coli F, 
Achromobacter xylosoxidans. Phage AZ1 produced a plaque size of 0.3 to 1.0 mm in 
diameter and infects only P. aeruginosa, P. aeruginosa-2949, P. aeruginosa-37, E. 
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coli CR-061 and Achromobacter xylosoxidans. Phage MJ2 produced a plaque size 
ranging from 1.0 to 5.0 mm in diameter and only E. cloacae, E. cloacae-101, E. 
cloacae-105 and Achromobacter xylosoxidans were found susceptible to it. Phage Z 
also produced clear plaques of size ranging from 0.5 to 3.0 mm in diameter and 
infected K. pneumoniae, K. pneumoniae-3206, K. pneumoniae-3 and Achromobacter 
xylosoxidans. Similarly, phage WZ1 produced plaques of size ranging from 0.4 to 2.0 
mm in diameter and only S. dysenteriaea, S. dysenteriaea-209, S. dysenteriaea-208 
and Achromobacter xylosoxidans were found susceptible to it.  
Among these bacterial strains used for host range studies, Achromobacter 
xylosoxidans was susceptible to all the phages, which indicates that this bacterium 
may possess receptor determinants for all of our isolated phages. 
Many phages are significantly specific for their receptors on the host cell 
surface (Piracha et al., 2014). The isolated phages were also infecting some other 
bacterial species besides their respective hosts, which shows that some of our virulent 
phages can also use some alternative receptor determinants for their adsorption. Some 
of our phages apart from the host bacteria, showed activity against different bacterial 
species on a spot test, but no plaques were observed in the plaque assays, which 
suggests that this phenomenon was most probably due to the presence of cytolysins in 
the phage lysates produced by host bacteria to inhibit the growth of other bacterial 
species (Hickey et al., 2003). 
We determine both the heat and pH stability of all the five phages as these 
physical parameters i.e. temperature and pH have direct relation with phage survival 
and activity (Puck et al., 1951; Adams, 1959). Phage with good heat and pH stability 
will most suitable for phage theapy or bacterial control. 
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Ackermann (2007) states that most of the phages can withstand a wide range of 
environmental conditions and most of the phages with tails exhibit a pH stability 
ranging from 5 to 9 and are normally inactivated by heating at 60 
o
C for 30 min. The 
isolated phages demonstrated a range of heat stability and pH. They were relatively 
stable up to 70 °C and showed highest stability at 37 °C. Our results for heat stability 
are almost comparable with Haq et al. (2012). The phages also showed better pH 
stability and were relatively stable at pH ranging from 5-11. Our results for pH 
stability are almost comparable with Carey-Smith et al. (2006) and Jamalludeen et al. 
(2007). Our phages were inert at pH values of 1 and 3 except phage AZ1 which was 
even stable at pH value 3. Phages are often sensitive to protein denaturation in an 
acidic environment (Hazem, 2002) and this unique feature of phages may be utilized 
in different environments. 
The infectivity of phages was demonstrated to be increased at concentration of 
10 mM magnesium chloride or calcium chloride (Figure 4.12 and 4.13). Gill and 
Abedon (2003) showed that phage adsorption to host is generally a function of the 
phage-bacterium physicochemical interaction. It is reported by Chhibber et al. (2014) 
that there occurs a significant increase in absorption of phage titer in presence of 5 
mM CaCl2 than the phage titer absence of any supplemented cations. Guttmann et al. 
(2005) demonstrated that cofactors e.g. Ca
2+
, Mg
2+
, divalent cations or sugars may be 
essential for successful binding. It is anticipated that there is an electrostatic bonding 
effect of ions in interactions of phage with the receptors on bacterium surface (Reese 
et al., 1974; Briandet et al., 2008). The weak interaction of virion and receptors on 
bacterium surface are satblized by Ca
2+
/Mg
2+
 ions during the adsorption phenomena. 
A range calcium ions quantities give maximum infectivity for various phages (Reese 
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et al., 1974; Donlan, 2005). It is also postulated that Ca
2+
 ions may have a role to 
enhance the concentration of phage particles at the host surface. Ca
2+
 ions may also 
have the ability to modify the structure of a cell surface receptor leading to more 
accessibility of the receptor molecules or the transfer of phage nucleic acids 
(Watanabe and Takesue, 1972; Russel et al., 1988). 
Protein compositions of all five phages were detected by SDS-PAGE 
separately (Figure 4.21). In each of the phages MJ1 and MJ2 eleven proteins were 
detected with molecular weight ranging approximately from 17 to 200 kDa and 12 to 
150 kDa respectively. Seventeen proteins with molecular weight ranging 
approximately between 12 and 110 kDa were observed in phage AZ1. Six proteins 
were detected in phage Z with molecular weight from 18 to 65 kDa while in phage 
WZ1 twelve proteins were detected ranging from 22 to 150 kDa. 
Dunn and Studier (1983) have reported 9 structural-protein bands for the T7 
phage and Pope (2005) have determined by SDS-PAGE that phage Syn5 is comprised 
of 12 structural proteins. Sanlibaba et al. (2005) have determined structural proteins 
profiles for 24 phages through SDS-PAGE and have reported 24-31 total structural 
proteins with molecular weights ranging from 6.5 to 208.9 kDa. Chang et al. (2005) 
stated that phage φSMA5 belongs to the Myoviridae family, revealing 25 proteins by 
SDS-PAGE with molecular weight ranging from 17.6 to197 kDa. Haq et al. (2012) 
have reported six proteins for phage IHQ1 of the family Myoviridae by SDS-PAGE 
ranging from 25 to 70 kDa. Hence it can be concluded that phages belonging to 
different families, as well as to one and the same family have a different protein-
composition and protein molecular masses. 
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A one-step growth curve assay can elucidate all the stages involved in the 
reproduction of phages. The mean yield of the phage was used to determine the brust 
size. The latent time periods of phages, MJ1, AZ1, MJ2, Z and WZ1 was 21, 33, 21, 
24 and 24 min respectively while the burst sizes were 300, 326, 350, 320 and 430 
phages per cell respectively (Figure 4.12 and 4.13). The average number of phage 
particles produced per bacterial cell upon infection is defined as phage’s burst size 
(Piracha et al., 2014).  
According to Delbriick (1946) a phage’s latent period depends on the strain of 
both the phage and the host (bacteria), and also on the environmental conditions 
(media, temperature). Delbriick (1946) and Adams (1951) state that different phages 
growing on the same bacterial strain may have quite different latent periods, as well 
as very closely related phages (i.e. T2, T4, T6, T5 and PB) may have quite different 
latent periods in the same host. The latent period is strongly affected by the 
physiological state of the host cell (Delbriick, 1940). According to Adams (1949) the 
latent time of the same phage may vary from one medium to other. He found a latent 
period of 55 min in synthetic medium for phage T5, whereas only 40 min in broth. 
Similarly, according to Delbriick (1946) the average phage burst size depends 
on the strain, the host cell, as well as on the environmental conditions. For example 
different phages growing in the same host strain may have quite different burst sizes, 
while Barry and Goebel (1951) stated that the same phage growing in different host 
strains may also have different burst sizes. Delbriick (1940) has demonstrated the 
effect of the physiological state of the host, by detecting an average burst size of 20 
within resting bacteria, and of 170 within growing bacteria. Heden (1951) stated that 
the phage burst size is generally much larger in nutrient-rich broth, compared to 
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synthetic media. Doermann (1948) stated that delaying the lysis time of the bacterial 
cell results in an up to more than double increase of the burst size. Hence it can be 
concluded that definition of the latent time and burst size of bacteriophages is 
controversial. Various parameters such as inoculation timing, bacteriophage 
absorption rate to the host and burst size are important regarding phage therapy 
(Payne and Jansen, 2001; Weld et al., 2004). 
Ackermann (2005) stated that at present, the International Committee on 
Taxonomy of Viruses (ICTV) recognizes one order, 13 families and 31 genera of 
bacteriophages. The first six basic phage-morphotypes were characterized by the 
nature of the nucleic acid and gross morphology. Therefore, on the basis of the phage 
morphology (electron microscopy analysis) and to some extent on their genomic 
nature, we classified the isolated phages into three families, Corticoviridae, 
Siphoviridae and Myoviridae according to ICTV rules of nomenclature. The three 
phages named MJ1, AZ1 and WZ1 were assigned to Myoviridae (contractile tail), 
phage Z was assigned to Siphoviridae (non-contractile tail), while phage MJ2 was 
assigned to Podoviridae (very short tail). In our results, all five phages (MJ1, AZ1, Z, 
WZ1 and MJ2) have tails, and hence belong to the order Caudovirales. Ackermann 
(2007) stated that out of 5500 phages examined by electron microscopy, about 96.2% 
are tailed and only (3.7%) are polyhedral, filamentous, or pleomorphic. Matsuzaki et 
al. (2005) stated that most of the reported phages (96 %) are “tailed phages”. 
Generally, phages consist of an icosahedral head and a tail. Phages with tails have a 
genome consisting of dsDNA and are classified into three families according to the 
morphological features of their tail: Myoviridae (contractile tail) Siphoviridae (long 
non-contractile tail), and Podoviridae (extremely short tail). These three families 
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comprise the order Caudovirales. The non-tailed phages (4 %) are classified into ten 
families and have cubic, pleomorphic or filamentous heads, with genomes comprised 
of ds or ssDNA or RNA. Most of the reported therapeutic bacteriophages are tailed, 
but some cubic or filamentous phages have also been used. 
All of our phages had double standard DNA genomes of variable size. Phages 
MJ1, AZ1, MJ2, Z and WZ1 have genome sizes of approximately 32 kb, 50 kb, 40 kb 
36 kb, and 38 kb, respectively (Figure 4.22). The sizes of a phages’ genomes may 
vary in length from very small, containing 3600 bp (e.g. E. coli phage R17 have only 
4 genes), to very large containing 2.5x10
5
 bases (e.g. E. coli phage PB51 have about 
240 genes) (Birge, 1994). Additionally, upon EcoR1 restriction, the nucleic acids of 
phages MJ1, AZ1, MJ2, Z and WZ1 gave 2, 9, 2, 2 and 3 bands of different sizes, 
respectively. 
Various methods have been reported in literature for detection of bacterial 
biofilms, such as scanning electron microscopy, Congo Red agar (CRA) method, 
tissue culture plate (TCP), tube method (TM) and bioluminescent assay (Kaiser et al., 
2013). We used tissue culture plate methods for initial selection of biofilm forming 
bacteria among thirty (30) different bacterial strains. Mathur et al. (2006) have 
reported that the TCP method is the most receptive, consistent and precise method for 
detection of biofilm formation by clinical isolates of Staphylococci, which can be 
used as a model for biofilm quantification. Similarly, Hassan et al. (2011) have 
reported that the TCP method is a more quantitative and dependable method for the 
recognition of biofilm forming microorganisms as compared to TM and CRA 
methods. TCP is recommended as the best option for recognition of biofilm forming 
bacteria in laboratories. We used 1 % glucose in trypticase soy broth (TSB) since the 
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addition of glucose promotes the formation of biofilms (Mathur et al., 2006; Bose et 
al., 2009). The selected biofilm-forming bacterial strains (i.e. K. pneumoniae, E. coli, 
P. aeruginosa, E. cloacae and S. dysenteriae) were tested for antibiotic resistance 
using ten different antibiotics (Table 4.6). All these bacterial strains were exhibiting 
multi-drug resistance. 
Bacterial biofilm is infectious in nature and can result in nosocomial 
infections. Bacterial viruses (bacteriophages) have been used for treatment of human 
diseases, and researchers are interested to use phages for bacterial biofilm-control. 
Propagation of phages occurs in direct correlation to bacterial hosts and many phages 
have the ability to produce depolymerases that destroy bacterial biofilm (Donlan, 
2009). 
Biofilm organisms are resistant to disinfectants, antimicrobial drugs and 
biocides (Mah and O’Toole, 2001). Generally a high concentrations of antimicrobials 
for prolonged time period is required to attain biofilm reduction or eradication (Ceri et 
al., 1999). A phage specific for a bacterium can infect biofilm cells by disrupting the 
EPS leading to the ultimate lysis of the bacterial cells. There is evidence that phage-
induced depolymerases could affect biofilms. Treatment of biofilms of Enterobacter 
agglomerans and Serratia marcescens with phages can significantly reduce biofilms, 
and treatment of a P. agglomerans strain with phage also decreased biofilm levels 
(Hughes et al., 1998). Phages can take control over biofilm formation (Roy et al., 
1993; Hughes et al., 1998). According to Carson et al. (2010) bacteriophages have 
capability to prevent and reduce bacterial biofilms formation on the surfaces of 
medical-devices. There was approximately 90 % reduction in E. coli biofilm by phage 
therapy on catheters as compared to untreated controls. 
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Interestingly, we observed that planktonic cells from each bacterial strain at 
exponential phase of growth were much more susceptible to lysis by their respective 
phage than bacterial cells at stationary phase of growth. This observation was 
previously demonstrated on P. fluorescens planktonic cultures (Sillankorva et al., 
2004) and also on the susceptibility of Staphylococcus epidermidis planktonic cells 
(Cerca et al., 2007). It seems that biofilm cells of each bacterial strain are gradually 
killed by their respective phages which may not be attributed to a specific biofilm 
phenotype but most probably due to the low metabolic activity of biofilm cells 
(Costerton and Lappin-Scott, 1995; Beveridge et al., 1997). 
According to the study of Corbin et al. (2001), there was 1.5 log reduction of 
E. coli biofilms formation by applying T4 phage therapy while Moons et al. (2006) 
demonstrated that one-hour treatment with phage T7 at a concentration of 10
10
/ml on 
E. coli biofilm formation resulted in almost 2-fold reduction. Our study showed a 
little bit more then 2-fold reductions of both 24 h and 48 h biofilms of E. coli by 
phage therapy at 4.5×10
9 
PFU/ml concentration. There was observed more than 3-fold 
reduction of both 24 h and 48 h biofilms of E. cloacae, when treated with their 
respective phage titer of 2×10
9 
PFU/ml. Furthermore there was almost 2-log reduction 
of both 24 h and 48 h biofilms of K. pneumonia for a  phage titer of 4.5×10
9 
PFU/ml. 
Additionally, we observed that a phage titer of 2.6×10
9 
PFU/ml  applied on both 24 h 
and 48 h biofilms of S. dysenteriae  reduced almost 1.5-fold biofilm growth. The 
optimum MOI for P. aeruginosa was 1.0 (≈ 2.5 x10
8
 PFU/ml),
 
which caused 
maximum reduction in bacterial growth (OD measured). The treatment of planktonic 
cells in exponential growth phase with phage cocktails was much more potential than 
treatment with phage AZ1 alone. This type of sensitivity has been earlier shown on P. 
 Chapter 5                                                                                                        Discussion                                                                                                                                                    
                                                                                                                                                                                            
                                                                 
 
  144 
 
fluorescens planktonic cultures (Sillankorva et al., 2004) and also on Staphylococcus 
epidermidis planktonic cells by using a single phage (Cerca et al., 2007). 
Kutter and Sulakvelidze (2004) have suggested that biofilm resistance can be 
reduced or overcome by phage cocktails containing two or more phages. During 
cocktail treatment the phages bind to different receptors of a bacterium cell and cause 
its lysis, thus lowering the chance of development of bacterial resistance. A phage 
cocktail suspension of 3 different phages have achieved a complete eradication of 24 
h biofilms E. cloacae by exposing the biofilms for 24 h (Tait et al., 2002). We 
observed approximately 3-log reduction in 48 h biofilms treated with a single phage 
(titer of 2×10
9 
PFU/ml), but we obtained more then 5-fold reduction (approximately 
total removal) in biofilms treated with a phage cocktail, showing a nearly complete 
correlation of our results with the results of Tait et al. This study suggests that phage 
cocktails should be used to avoid bacterial resistance, and that the use of phage 
cocktails is a very good approach for controlling both planktonic cells and biofilms, 
when compared to using a single specific phage. 
Peters et al. (1982) stated that scanning electron microscopy (SEM) is a well-
established methodology for the determination of bacterial morphology adhered to the 
surface, bacterial biofilm and also the relationship between them (Eighmy et al., 
1983; Richards and Turner, 1984). 
It has been proven by electron microscopic studies that biofilms are the name 
of dense bacterial cells in a dense exopolysaccharide matrix (Eighmy et al. 1983; 
Blenkinsopp and Costerton, 1991). The present knowledge regarding biofilm is due to 
the advances in imaging studies, especially the by current new inventions such as 
SEM (El Abed, 2012). 
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We also used scanning electron microscopy (SEM) methods for detection of 
K. pneumonia, E. cloacae, and P. aeruginosa biofilms. Biofilms of clinical strains of 
K. pneumoniae and E. cloacae were developed on stainless steel plates using time 
spins of 24 h, 48 h and 72 h in both static and dynamic conditions with and without 
media removal. After development of biofilms specific bacteriophages were applied 
as treatment option for biofilm reduction. Phages reduced biofilms and considered to 
have enzymes that can disrupt EPS of biofilm (Figure 4.31 and 4.33). Fu et al. (2010) 
stated that phage enzymes have the ability to reduced bacterial biofilms. Our data 
suggests that at static conditions the biofilms were properly developed, whereas 
biofilm-formation under dynamic conditions was slightly reduced. These results 
correspond to the results of Sillankorva et al. (2008). 
Dry weight of biofilms of E. cloacae and K. pneumoniae formed for different 
time intervals and conditions were calculated before (control) and after biofilm 
treatment (phage application). Lopes et al. (2000) stated that the dry mass of a biofilm 
is mainly comprised of two components, extracellular polymers (EPS) and microbial 
cells. We observed a significant difference between dry masses of treated and 
untreated (control) biofilms of both E. cloacae and K. pneumoniae. It was observed in 
the current study that biofilm reduction upon phage therapy was a little more effective 
under static conditions than dynamic conditions as previously reported by Sillankorva 
et al. (2009). Phage adsorption was dependent on the infectious conditions i.e. a static 
condition encouraged adsorption of phages while the dynamic condition caused 
hindrances in phage adsorption. 
E. cloacae biofilm (Figure 4.29) formed under different conditions showed a 
variable reduction pattern after treatment with phage MJ2 for 4 hours. Biofilms 
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formed under static conditions with renewal of media for 24 h, 72 h and 120 h showed 
a reduction of 3-log, 3.2-log and 4-log, respectively (A), while biofilms under 
dynamic condition with renewal of media at same times as under static conditions 
showed reduction of 2.5-log, 3-log and 3.5-log, respectively (B). On the other hand, 
biofilms under static conditions without renewal of media showed a biomass 
reduction of 2.8-log and 3-log, respectively (C). 
Similarly, K. pneumoniae biofilms (Figure 4.31) formed under different 
conditions showed variable reduction pattern after treatment with phage Z for 4 hours. 
Biofilms under static conditions with renewal of media for 24 h, 72 h and 120 h 
formed showed biomass reduction of 2.3-log, 2.2-log and 3.2-log, respectively (A), 
while biofilms under dynamic condition with renewal of media for 24 h, 72 h and 120 
h showed a reduction of 2.2-log, 2.3-log and 3.2-log, respectively (B). Biofilms 
formed under static conditions without renewal of media showed a biomass reduction 
of 2.1-log and 3-log, respectively (C). 
The effect of the phages on the formation of E. cloacae and K. pneumoniae 
biofilms under static conditions was noticed for 24 h, 48 h and 72 h by scanning 
electron microscope analysis (Figure 4.30 and 4.32). Biofilms were observed as dense 
molecule aggregates before phage therapy however after phage therapy there were 
found single bacteria with cellular debris on stainless steel plates showing that 
bacteriophage treatment had eradicated biofilms. Both phages showed a very good 
reduction potential on biofilms, but the effect was more prominent in the case of 
phage MJ2. No total eradications were observed, which indicates that a combination 
of phages (cocktail) may be needed to result in total biofilm eradication. Similarly, in 
the case of P. aeruginosa biofilms developed on steeliness steel, we observed a more 
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prominent effect when using a phage cocktail, compared to the effect after use of 
single phage treatment. 
In conclusion, all the phages isolated form waste water had a dsDNA genome, 
ranging for 30 to 50 kb, and had a wide range of heat- (temp; 37- 70 
o
C) and pH-(pH; 
5-11) stability. The phages have proved to tolerate high temperature and pH-change 
that make phage application more effective. The phages were also more effective in 
lysis of planktonic bacterial cells in the exponential growth phase than of cells in a 
stationary growth phase. The phages were also effective in the eradication of biofilms, 
but no total eradication was observed for any of the single phages. However, our 
phage-cocktail study showed a very remarkable effect causing nearly complete 
eradication of biofilms, thus proving the higher efficacy of cocktails, when compared 
to single phage therapy. The fact that phages are highly selective for their bacterial 
hosts makes them a promising tool for the treatment of bacterial infections. We have 
shown that an individual phage might not be able to completely control bacterial 
biofilms, but a phage cocktail (combination of different phages) is more effective, 
therefore phage cocktails may serve as better treatment strategies for bacterial biofilm 
control and treatment. 
In future, we would like to perform elaborate studies on biofilms, such as 
phage and bacterial interaction in biofilm, as well as formation of biofilms of dual- or 
multiple-species nature (having two or more different bacterial strains) under different 
conditions (temperature, dynamic/static, media). Additionally, we would like to test 
anti-biofilm efficacy of phage cocktails (a combination of multiple phages; two or 
more) at different multiplicities of infection (MOIs). 
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The complete molecular characterization of the phages and development of 
animal models to study the in-vivo effects of bacteriophages would be very helpful in 
future phage therapy of biofilms treatment. The sequencing of phage genomes 
specifically their lytic genes (such as lysogene) would be very helpful in phage 
therapy. The high specificity of the phage-host relationship and the formulation of 
phage cocktail can be used to treat bacterial infections. The phage cocktails are 
currently used as an effective treatment option at the George Eliava Institute of 
Bacteriophage, Microbiology and Virology, Republic of Georgia.  
           Phage cocktail could induce bacterial lysis and reduce the evolution of phage 
resistance. Phage cocktail might also be used in controlling mixed-culture (multi-
bacterial) biofilms. There may also be produced genetically modified phages by 
inserting EPS degrading enzyme-genes into the phage genomes and enhancing their 
capability to disrupt biofilms. 
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